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Epidemiological studies have shown that natural fruits and vegetables possess 
vital compounds that can be used to treat diseases including cancer. Resveratrol 
(RSV), a phytoalexin found in grapes’ skins has been extensively documented on 
its highly promising potential in a variety of disease models. Amidst its properties 
feature its antioxidant ability, inhibition of cell proliferation and targeting of 
transcriptional machinery. Recent work has revealed that RSV and its analogs 
could elicit either a pro-oxidant or antioxidant effect in cell culture models. 
 
The interplay between redox regulation of cell death and survival with cytosolic 
pH has implicated Na+/H+ exchanger 1 (NHE1) as a critical target of intracellular 
ROS. To that end, an increase in superoxide anion (O2.-) enhances NHE1 promoter 
activity and protein expression while addition of exogenous hydrogen peroxide 
(H2O2) repressed both promoter activity and protein expression. The regulation of 
NHE1 gene expression by ROS is mediated by redox-regulated transcription 
factors. 
 
Considering the ability of RSV to alter cellular redox status and induce apoptosis 
in tumor cells, the death promoting effect of intracellular acidification and the 
effect of ROS on NHE1 antiporter, the role of RSV on NHE1 promoter activity 
and gene expression with respect to cellular redox status was investigated. 
 
Results show that RSV triggers intracellular ROS production leading to repression 
of NHE1 promoter activity and protein expression via the activation of caspase-3 
and caspase-6. The induction of caspase-3 activity by RSV at an early time phase 
seems to be responsible in ROS production. On the other hand, RSV activates 
caspase-6 at a later time which was in turn dependent on ROS production.   
 
In light of the role of NHE1 in the development of carcinogenesis, these findings 
provide a novel mechanism of action of RSV with potential implications for 
treatment of tumor cells.
 ix
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Chapter 1. Introduction 
1.1 Resveratrol  
The identification of resveratrol (RSV) as a constituent of white hellebore’s roots 
(Veratrum grandiflorum O. Loes) dates back to 1940 (Takaoka 1940). Afterwards, 
RSV was also found in the roots of Polygonum cuspidatum, called Ko-jo-kon in 
Japanese, used in Chinese and Japanese medicine to treat several diseases such as 
suppurative dermatitis, gonorrhea favus, athlete’s foot (tinea pedis) and 
hyperlipidemia (Takaoka 1940; Lee et al. 1998; Vastano et al. 2000; Cichewicz 
and Kouzi 2002). RSV is present in a number of dietary sources including red 
grapes, muscadine grapes, cranberries, bilberries, blueberries, lingonberries, 
sparkleberry, deerberry, partridgeberry and peanuts. RSV exists as a natural 
phytoalexin (“alexin” is a Greek word meaning to ward off or to protect) in plants 
as a defensive shield against fungal infections (Stewart et al. 2003) and other 
environmental stress-factors such as ultraviolet radiation (Creasy and Coffee 
1998). RSV which is found in the leaf epidermis and not the flesh of grapes 
(Langcake and Pryce 1976; Langcake and McCarthy 1979; Creasy and Coffee 
1998) is synthesized by plants prior to any mould lesion caused by pathogens 
(Schwekendiek et al. 1992). This protective anti-fungal response of RSV is 
indicative of its potential to control the microbiota on fruits (Jeandet et al. 2002) 
and thus constitutes itself as a promising chemical to prolong the shell-life of 
fruits (Hawksworth DL, 2003). RSV became popular in 1992 after it was 
discovered in red wine and implicated in the “French paradox”, an 
epidemiological finding linking an inverse relationship between red wine 
consumption and incidence of heart disease (Kopp 1998; Sun et al. 2002). In 
1997, it was demonstrated that RSV had cancer chemopreventive properties. 
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Subsequently, RSV has been under intense investigation both in cardiac and 
cancer research arenas (Jang et al. 1997). 
1.2 Antioxidant potential of RSV 
1.2a Cardio-protective effects of RSV- RSV inhibits atherosclerosis via 
suppression of LDL oxidation 
One prominent antioxidant role of RSV stems from its ability to confer 
cardioprotection.  Epidemiological studies have shown that moderate consumption 
of 150 to 300ml/day of red wines can substantially decrease coronary heart 
disease (Renaud and de Lorgeril 1992; Renaud et al. 1998). Atherosclerosis is 
characterized by an accumulation of lipids in the arterial wall. Low density 
lipoprotein (LDL) is the major player in causing atherosclerosis and is formed by 
remodeling of very low-density lipoproteins (VLDL) and the exchange of 
lipids/proteins with high density lipoproteins (HDL). Despite the lack of concrete 
evidence about the exact mechanism of LDL oxidation in vivo, there are 
indications that it is due to the products of polyunsaturated fatty acid (PUFA) 
oxidation and apolipoprotein B-100 molecules (Apo B-100) (Fremont 2000). 
Oxidized LDL is taken up by “scavenger receptors” found on subendothelial 
macrophages and “nonprofessional” phagocytes leading to the development of 
atherosclerotic plaques (Ferroni et al. 2004). RSV has been shown to protect LDL 
molecules against peroxidation via its antioxidative and metal-chelating ability. 
LDL has a high ability to bind copper which is involved in lipid peroxidation and 
addition of RSV chelates copper thus hindering LDL oxidation (Frankel et al. 
1993). Besides, RSV was shown to inhibit PUFA oxidation in LDL and further 
studies emphasized the peroxyl radical scavenging activity of RSV by impeding 
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the formation of malondialdehyde (MDA) – a product of lipid peroxidation (Ray 
et al. 1999; Mizutani et al. 2001). 
1.2b Anti-cancer property of RSV 
An imbalanced level of intracellular ROS plays an important role in the 
development of tumorigenesis. Peroxynitrite (ONOO-) and hydroxyl radical (OH.) 
are known to engender DNA lesions such as strand breaks, modification of 
purines and pyrimidines. The most frequent mutations from ROS oxidation are C 
to T transitions and C to G transversions (Wiseman and Halliwell 1996). Such a 
nucleotide change leads to a profound effect on the DNA conformation and 
stability, the prerequisite criteria for tumor formation. RSV has the ability to offset 
DNA damage by two pathways: (i) as an antioxidant to eliminate free radicals and 
(ii) as an antimutagen by inducing phase II enzymes, like quinone reductase. 
Quinone reductase thus detoxifies carcinogens by inhibiting the formation of 
muatations induced by cycloxygenase and cytochrome P450 1A1 enzymes 
(Roemer and Mahyar-Roemer 2002). Furthermore, free radicals derived from lipid 
peroxidation and together with MDA and other aldehydes may function as tumor 
initiators. However, RSV has been shown to protect cells against lipid 
peroxidation and DNA damage induced by ROS. Tumor promoter such as TPA is 
associated with increased production of O2.- and H2O2, decrease of SOD activity 
and interference with glutathione metabolism (Gusman et al. 2001). In a model of 
TPA application to mouse skin, RSV restored the H2O2 and glutathione levels as 
well as the activities of SOD, myeloperoxidase and GSSG-reductase (Jang and 
Pezzuto 1999). 
Short-term damages engendered by UV radiation are often deemed as precursors 
for the development of skin tumors. Topical application of RSV (25µmol/0.2ml 
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acetone/mouse) to SKH-1 hairless mice inhibited UVB (180mJ/cm2) exposure-
mediated skin edema, inflammation, cycloxygenase (COX) and ornithine 
decarboxylase (ODC) enzyme activities, ODC protein expression, lipid 
peroxidation and H2O2 production (Afaq et al. 2003). ODC which is considered to 
play an important role in growth and development of tumors (Shantz and Pegg 
1999), COX enzyme known to be involved in cancerous inflammatory processes 
(Zha et al. 2004) and H2O2 production which is marker of oxidative stress linked 
to tumor formation (Schrader and Fahimi 2004) are all inhibited by RSV, most 
probably via the antioxidant ability of the polyphenolic compound (Afaq et al. 
2003). 
1.2c Neuroprotection 
Alzheimer’s disease is characterized by the progressive formation of β-amyloid 
plaques containing β-amyloid peptides and the plaques can induce oxidative stress 
that leads to protein oxidation and lipid peroxidation, thus disturbing the normal 
functioning of cell membranes (Yankner 1996; Lovell et al. 1998; Yatin et al. 
1998). RSV has the potential to restore GSH levels to counteract the surge in 
reactive oxygen species (ROS) caused by the β-amyloid plaques (Savaskan et al. 
2003). Rat primary hippocampal cell cultures incubated with RSV were protected 
from cell death induced by sodium nitroprusside via the formation of intracellular 
ROS (Bastianetto et al. 2000; Bastianetto and Quirion 2002). RSV (10 to 40 µM) 
was able to promote cell survival in PC12 (Jang and Surh 2001; Conte et al. 2003; 
Jang and Surh 2003), SH-SY5Y (Savaskan et al. 2003) and primary hippocampal 
cells (Han et al. 2004) exposed to Aβ peptides . Furthermore, RSV pretreatment of 
primary dorsal root ganglion explant neurons which were exposed to axotomy had 
a subdued axonal degradation (Araki et al. 2004). 
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1.2d Hepatoprotection 
Oxidative damage induced by lipid peroxidation in NADPH, Fe-ascorbate and Fe-
microsomal systems of rat liver was impeded by RSV (Ozgova et al. 2003). 
Moreover, unabated proliferation of stellate cells and collagen synthesis are linked 
to hepatic fibrogenesis (Casini et al. 1994; Lee et al. 1995). RSV has been shown 
to curb the oxidative stress-mediated stellate cell activation, thus inhibiting liver 
disease (Kawada et al. 1998). Hepatic CYP1A enzyme is involved in xenobiotic 
metabolism. Benzo[a]pyrene, a cancer inducer, was found to stimulate the 
expression and activity of CYP1A in cultured primary trout hepatocytes (Tsuji 
and Walle 2007). However, RSV was shown to be effective in inhibiting the 
increased activity of CYP1A (Tsuji and Walle 2007). 
1.2e RSV reduces levels of NO.  
Aberrantly high levels of NO. and its derivatives ONOO- or NO2 are deleterious to 
various tissues. Increased NOS induction and activity has been linked with tumor 
development and vascular invasion. The effect of RSV and another natural 
hydroxystilbene, oxyresveratrol were investigated on nitrosative and oxidative 
stress derived from microglial cells (Lorenz et al. 2003). RSV significantly 
reduced NO. production upon expression of the inducible isoform of NOS (iNOS). 
It also induced an inhibitory effect on the activity of iNOS (Lorenz et al. 2003). 
Bacterial endotoxin LPS is a potent inducer of iNOS with the aftermath being an 
increase in NO. that has bactericidal effects. In LPS-activated RAW 264.7 
macrophages (Tsai et al. 1999; Wadsworth and Koop 1999) and LPS-treated 
mouse peritoneal exudate macrophages (Matsuda et al. 2000), preincubation with 
RSV reduced inflammation via down-regulation of iNOS gene expression and 
subsequently NO.. In another study, RSV (10-100 µM) significantly and dose-
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dependently inhibited the formation of reactive nitrogen intermediates in rat 
macrophages stimulated with thioglycollate (Leiro et al. 2002). These results 
demonstrate that RSV is a potent inhibitor of the antipathogen responses of rat 
macrophages and therefore highlight its potential benefits in treatment of diseases 
associated with macrophages hyper-responsiveness (Leiro et al. 2002). 
1.3 Effect of RSV on transcription factors 
It is widely recognized that RSV has several intrinsic abilities that dictates its 
pleiotropic molecular effects. One of these effects is the regulation of the activity 
of transcription factors in several pathogenic states. 
1.3a NFκB 
Existing as a heterodimer formed by the Rel family (eg p65/Rel A, p50, p52, c-
Rel, v-Rel and Rel B), NFκB resides in the cytosol of unstimulated cells as an 
inactive non-DNA binding complex associated with the inhibitory protein IκB. 
Following cell stimulation with various NFκB inducers (like Ca2+ ionophores, 
TNFα), IκB is rapidly phosphorylated on Ser 32 and 36 before subsequent 
ubiquitination and degradation by the 26S proteasome (Baldwin 1996; Ghosh and 
Karin 2002). NFκB dimer is thus able to translocate to the nucleus and the p65 
subunits are acetylated and activated by histone acetyltransferase (HAT). 
Activated NFκB has the potential to free NFκB-regulated genes from repressors 
such as histone deacetylases (HDAC) and promote transcription (Ashburner et al. 
2001; Baek et al. 2002; Zhong et al. 2002). 
RSV affects the stimulation of NFκB induced by different inflammatory agents 
rather than modulating NFκB directly. This observation has been made in several 
cell lines including HeLa, Jurkat and U937 whereby addition of RSV eschewed 
NFκB activation by LPS, okadaic acid, TNFα, H2O2 and PMA (Manna et al. 
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2000). Contrarily to the mode of action of well-known inhibitors of NFκB (like 
herbimycin A and caffeic acid phenylethyl ester) that target its DNA binding 
activity, RSV seems to prevent phosphorylation and nuclear localization of the 
p65 subunit (Holmes-McNary and Baldwin 2000). However, RSV-mediated 
inhibition of phosphorylation and degradation of IκB is debatable (Ashikawa et al. 
2002). An additional intriguing hypothesis is that RSV inhibits the acetylation of 
NFκB by stimulating a protein deacetylase acitivity. 
1.3b AP-1 
Members of the AP-1 family are structurally and functionally related and are 
characterized by a basic leucine-zipper region. The Jun protein family (c-Jun, 
JunB and JunD) and the Fos protein family (c-Fos, FosB, Fra-1 and Fra-2) make 
up the AP-1 family members (Milde-Langosch 2005). Unlike Jun proteins, Fos 
family members cannot form homodimers but heterodimerize with Jun proteins to 
give rise to trans-activating or trans-repressing complexes (Mason et al. 2006). 
According to in vitro studies, the Jun-Fos heterodimers are more stable and 
display stronger DNA-binding activity than Jun-Jun homodimers (Halazonetis et 
al. 1988; Ryseck and Bravo 1991). Using RSV, the activation of AP-1 by TNF-α 
is abrogated (Manna et al. 2000). Given that RSV inhibits TNF-α -dependent 
activation of MEK/JNK and both MEK/JNK are known to activate AP-1, it is 
postulated that repression of MEK/JNK is pivotal in the AP-1 inhibition by RSV 
(Karin and Delhase 1998). In addition, pretreatment of TPA-stimulated mouse 
skin with RSV inhibited AP-1 DNA binding activity (Kundu et al. 2004). A 
similar finding on AP-1 DNA binding activity was obtained when U937 cells 
were treated with RSV (Li et al. 2003b).  
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1.3c Steroid receptors 
1.3c (i) Aryl hydrocarbon receptors (AhR) 
A major established chemopreventive function of RSV resides in its ability to 
inhibit tumors caused by treatment with aryl hydrocarbon DMBA (7,12-
dimethylbenzanthracene) (Jang et al. 1997). Aryl hydrocarbon entails an initial 
interaction with cytosolic AhR. The activated AhR translocates into the nucleus 
where it binds to the xenobiotic responsive element (XRE) (Nebert et al. 1993; 
Okey et al. 1994), responsible for regulating the expression of several isoforms of 
cytochrome P450 (CYP) enzymes including CYP1A1, CYP1A2, CYP1B1 and 
other phase II detoxifying enzymes (Rowlands and Gustafsson 1997). CYP 
isoenzymes form part of the constitutive or inducible heme-containing enzymes 
that are involved in the metabolism of carcinogenic elements which are thus able 
to mediate tumor formation (Nelson et al. 1996; Murray 2000). 
The role of RSV vis-à-vis AhR has been the object of several investigations and it 
seems that RSV hampers the genotoxicity of AhR at various levels. RSV 
decreased CYP1A1 mRNA/protein expression in cultured cells (Ciolino et al. 
1998; Casper et al. 1999; Singh et al. 2000; Lee and Safe 2001; Mollerup et al. 
2001). This was shown to occur by inhibiting the AhR binding to promoter 
sequences that control CYP1A1 transcription in HepG2 cells (Ciolino et al. 1998). 
Lee et al reported that RSV-mediated decrease of CYP1A1 mRNA took place in 
an AhR-independent post-transcriptional pathway (Lee and Safe 2001). Besides, 
studies have shown that RSV could compete for the substrate binding site on AhR 
(Chun et al. 1999; Ciolino and Yeh 1999; Chang et al. 2001; Piver et al. 2001). In 
addition, RSV inhibited AhR DNA binding activity and the resulting expression 
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of CYP1A1 and CYP1B1 in MCF-10A cells. CYP enzymatic activity was also 
affected by RSV. 
1.3c (ii) Androgen Receptor (AR) 
AR regulates androgen-dependent genes such as prostate-specific antigen (PSA), 
the glandular kallikrein and AR-specific coactivator ARA70 (Culig et al. 2002). 
RSV has been shown to inhibit the expression and function of AR. Using LNCaP 
(prostate cancer of the lymph nodes) tumor cells, RSV was shown to have a dual-
modulation on DNA synthesis. At 5-10 µM RSV, DNA synthesis was increased 
concomitant with the percentage of LNCaP cells in S phase and the expression of 
cyclin-dependent kinase 2 activity associated with cyclin A and cyclin E. At RSV 
dose >15 µM, DNA synthesis was impaired. However, using an androgen-
independent cell line, DU145, no such increase of DNA synthesis was observed 
(Kuwajerwala et al. 2002). 
1.3c (iii) Estrogen Receptor (ER) 
Upon agonistic ligand binding, ER binds to estrogen response element (ERE) in 
the promoters of target genes and stimulates transcription through their activating 
function (AF) domains (Nilsson et al. 2001). ERα and ERβ are the two distinct 
isoforms of ER with 53% sequence homology in ligand binding domain and 95% 
in DNA binding domain (Nilsson et al. 2001). RSV has been shown to bind both 
ERα (Gehm et al. 1997) and ERβ (Bowers et al. 2000; Bhat and Pezzuto 2001) 
but with a slight preference for ERα (Bowers et al. 2000; Mueller et al. 2004) 
unlike other phytoestrogens such as genistein and coumestrol which bind 
preferentially to ERβ (Kuiper et al. 1997; An et al. 2001; Mueller et al. 2004). In 
spite of its low binding affinity to both ER, several reports have shown RSV to 
have comparably high efficacy like estrogen 17β-estradiol (E2) or synthetic 
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estrogen diethylstilbestrol (DES) (Gehm et al. 1997; Bowers et al. 2000; Levenson 
et al. 2003; Wietzke and Welsh 2003; Gehm et al. 2004; Mueller et al. 2004).  
Artificial estrogen-responsive reporter genes were stimulated by RSV with an 
EC50 of 3-10 µM and maximal activity was seen at 10-30 µM, with the potency 
correlating on the number of EREs (Gehm et al. 1997). Using Cos-1 cells 
transfected with hERα, RSV (~50 µM) displayed full agonism on vit 
(vitellogenin) ERE, but only partial agonism on the luteinizing hormone β gene 
(Ashby et al. 1999). Besides the full and partial agonistic potential of RSV, 
several reports have explained the antagonistic nature of RSV, thereby 
highlighting the complexity surrounding the exact functions of RSV with respect 
to estrogenic-like activities. For instance, in Ishikawa endometrial cancer cells 
stably expressing hERα or hERβ, reporters comprising 3 vit EREs or the 
estrogen-responsive complement C3 promoter were fully stimulated by 20-50 µM 
RSV but high dose of 100 µM antagonized the activation by DES (Mueller et al. 
2004).  
1.4 Anti-inflammatory activity of RSV 
Chronic inflammation is regarded as the seeding ground for tumor development. 
Two enzyme systems involved in the synthesis of proinflammatory mediators are 
the cycloxygenase (COX) and lipoxygenase pathways (Cuendet and Pezzuto 
2000). COX-2 contributes to inflammatory processes via the generation of 
prostaglandins (Cuendet and Pezzuto 2000), prostacyclins and thromboxanes 
(Gierse et al. 1995) while leukocyte lipoxygenase catalyzes the formation of 5-
HETE (5-hydroxy-6,8,11,14-eicosatetraeinoic acid) (Kimura et al. 1995). RSV 
has been shown to inhibit H2O2-induced increase in PGE2 (product of COX 
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activity) and leukotriene B4 (product of lipoxygenase activity) concentrations in 
human erythroleukemia K562 cells (MacCarrone et al. 1999). 
Since AP-1 and NFκB are involved in the expression of pro-inflammatory genes 
like iNOS and COX-2, it is conceivable that RSV will have a major influence on 
their regulation as well (von Knethen et al. 1999; Hwang et al. 1997). iNOS 
contributes to an inflammatory milieu by generating NO. via the oxidative 
deamination of L-arginine (Surh et al. 2001). RSV inhibits COX-2 at 
transcriptional (Afaq et al. 2003; Subbaramaiah et al. 1998) and 
posttranscriptional levels (Jang and Pezzuto 1998; Li et al. 2002c). RSV thus 
attenuates TPA-induced prostaglandin by repressing COX-2 gene transcription in 
human mammary and oral epithelial cells (Subbaramaiah et al. 1998; 
Subbaramaiah et al. 1999). COX-2 (and COX-1, the counterpart involved in 
platelet aggregation) mRNA transcripts were down-regulated by RSV in N-
nitrosomethylbenzylamine (NMBA)-induced eosophageal tumors in F344 rats (Li 
et al. 2002c). However, there are conflicting reports suggesting TPA-induced 
expression of COX-1 and COX-2 remain unchanged in CD-1 mouse skin after 
RSV treatment (Jang and Pezzuto 1998). On the other hand, RSV had the ability 
to inhibit iNOS expression and therefore NO. production in LPS- and IFN-γ 
treated RAW 264.7 macrophages (Murakami et al. 2003). 
1.5 RSV as a regulator of apoptosis and cell proliferation 
Apoptotic cell death plays a fundamental role in the normal development and 
homeostasis of metazoans (Steller 1995; Jacobson et al. 1997). For instance, 
apoptosis occurs during morphogenesis or synaptogenesis in the developing 
embryo and during tissue turnover or at the end of an immune response in the 
adult animal. A defect in apoptotic mechanism can be deleterious as exemplified 
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by neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The failure 
of dividing cells to initiate apoptosis following substantial DNA damage leads to 
tumor development. There are hitherto two distinct pathways by which apoptosis 
occurs namely the extrinsic and intrinsic pathway (Thompson 1995) and RSV has 
been extensively documented to have an impact on both modes of apoptotic cell 
death. Apoptotic cell death is orchestrated via the activation of caspases. All 
known caspases possess an active-site cysteine and their substrate specificity is 
determined by a tetrapeptide sequence containing aspartate residues. Cleavage of 
the substrates takes place at Aspartate-XXX (that is after aspartate residue) 
(Thornberry et al. 1997). Subjected to a high dose of RSV, human leukemic HL60 
cells were found to undergo DNA fragmentation and externalization of inner 
membrane phosphatidylserine – major hallmarks of apoptosis. RSV up-regulated 
CD95L (FasL/Apo1L) expression in HL-60 cells as well as breast carcinoma 
T47D cells, thus driving CD95-dependent cell death (Clement et al. 1998a). 
However, using human peripheral blood lymphocytes (PBL), neither CD95L nor 
CD95 was induced by RSV and there was no evidence of cell death (Clement et 
al. 1998a). These findings were the first to report of RSV’s ability to function via 
an autocrine loop to trigger cell death through the induction of gene expression of 
death signals. Along the same line, human SW480 colon cancer cells treated with 
10-100µM RSV displayed Fas-dependent cell death (Delmas et al. 2003). In this 
case, RSV induced the formation of the death-inducing signaling complex (DISC) 
and redistributed it in cholesterol and sphingolipid rich fractions without the need 
to up-regulate CD95L expression (Delmas et al. 2003). This notable mechanism 
revealed that externalization of death receptors via their redistribution into lipid 
rafts is sufficient to elicit caspase activation following death receptor stimulation. 
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RSV enhances the effect of Apo2L/TRAIL in non-Hodgkin’s lymphoma (NHL) 
and multiple myeloma (MM) tumor cells via the inhibition of ERK1/2 pathway 
and repression of Bcl-xl (Jazirehi and Bonavida 2004). Besides, RSV acts as a 
potent sensitizer of tumor cells through p53-independent induction of p21Waf1 and 
surviving depletion associated with p21Waf1-mediated cell cycle arrest (Fulda and 
Debatin 2004). 
There are a reasonable number of reports which testify the involvement of RSV in 
mitochondria-dependent apoptosis. Exposure of HL-60 cells to RSV resulted in 
the loss of mitochondrial transmembrane potential and release of cytochrome c 
(Dorrie et al. 2001). Besides, RSV elicited the activity of caspases-3, -8, and -9 
with the translocation of Bax to the mitochondria in leukemic cell lines K562 and 
HSB-2 (Luzi et al. 2004). Similarly, RSV (10-200 µM) was shown to down-
regulate Bcl-2 and up-regulate Bax  (Lu et al. 2001; Park et al. 2001; Kuo et al. 
2002). However, it has been postulated that RSV has the potential to elicit 
mitochondrial-dependent apoptosis independent of Bax as well (Mahyar-Roemer 
et al. 2002; Lee et al. 2006).  
1.6 RSV regulates cell-cycle progression 
RSV has been shown to induce cell cycle arrest in a number of tumor cell lines. 
This growth inhibitory feature of RSV might be linked to its ability to block 
ribonucleotide reductase, a complex enzyme involved in the reduction of 
ribonucleotides into deoxyribonucleotides (Fontecave et al. 1998).  Besides, RSV 
was shown to inhibit DNA polymerase (Tsan et al. 2002) or ornithine 
decarboxylase (Schneider et al. 2000), a key enzyme that synthesizes polyamines 
required for tumor growth. Another layer of regulatory control by RSV concerns 
the cell-cycle checkpoint proteins, in particular p53, Rb, p27 and the cdk-inhibitor 
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p21Waf1/Cip1. In CEM-C7H2 acute leukemia cells and MCF7 breast cancer 
cells, RSV triggered an increase of cells in the S phase (Bernhard et al. 2000; Joe 
et al. 2002). This was accompanied by increase in expression of G1/S regulators 
such as cyclin D1, cdk4 and cyclin E in MCF7 cells (Pozo-Guisado et al. 2002). 
RSV induced cell cycle arrest in human promyelocytic leukemia HL60 cells at the 
S/G2 phase and subsequent increase in the G1/S phase concomitant with increase 
in cyclin A and E and inactivation of cdc2 (Ragione et al. 1998). In another study 
using A431 epidermoid cancer cells, RSV decreased the levels of cyclin D1, D2, 
E and cdk2 and cdk4/6 (Ahmad et al. 2001). 
1.7 Reactive oxygen species 
1.7a Definition and Source of Reactive Oxygen Species 
The term “reactive oxygen species” (ROS) denotes not only oxygen radicals (O2.- 
and OH.) but also non-radical derivatives of oxygen such as H2O2 (Halliwell and 
Gutteridge 1999). The adjective “reactive” is a relative concept since O2.- and 
H2O2 are biologically moderately reactive whereas OH. is highly reactive and is 
held accountable for most of the oxidative damage by ROS in biological systems 
(Halliwell and Gutteridge 1999). ROS is synthesized as part of the normal cellular 
metabolism and as a result of external stimuli activating membrane-bound enzyme 
complexes such as NADPH oxidase complex.  
1.7a (i) Mitochondrial electron transport chain  
The mitochondrial electron-transport chain (ETC) is a major site of ROS 
production. The ETC is a multi-component system which enables a series of 
oxidation-reduction (redox) reactions to take place between redox couples 
(Cadenas and Davies 2000). These redox reactions involve either the flow of 
electrons only as in the case of cytochromes or the coupled transport of electrons 
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and protons between NADH and FAD. The ability of isolated mitochondria to 
produce O2.- via (a) auto-oxidation of flavin component of NADH dehydrogenase 
(complex I) and (b) auto-oxidation of ubi-semiquinone at complex III, lends 
credence to the mitochondria being a major source of ROS formation (Halliwell 
and Gutteridge 1999) (Figure A). The terminal oxidase enzyme that consumes O2.- 
is cytochrome oxidase which is not known for releasing detectable free radicals in 
free solution. However, the generation of O2.- is attributed to the leakage of 1-2% 
of electrons, a process mediated by coenzyme Q and ubiquinone and its 
complexes (Halliwell and Gutteridge 1999).  
1.7a (ii) NADPH oxidase 
Another potent source of O2.- production is the membrane-bound NADPH oxidase 
complex which is made up of a membrane heterodimeric flavocytochrome 
(cytochrome b559) which comprises two subunits gp91phox and p22phox plus 
four cytosolic proteins p47phox, p67phox, p40phox (Babior 1999) in addition to a 
small guanosine triphosphate (GTP)-binding protein (Rac 1 and 2) (Kreck et al. 
1994; Kreck et al. 1996) (Figure B). The role of NADPH complex in formation of 
O2.- was initially known to occur in phagocytic cells (Dagher et al. 1995; 
Henderson and Chappel 1996; Babior 1999). Currently, there is evidence that 
similar oxidase systems such as mitogenic oxidase Nox 1 exists in other cell types 
as well as transformed cells (Irani et al. 1997; Suh et al. 1999). The generation of 
ROS in non-phagocytic cells stems from the activation of several signaling 
pathways including cytokine receptors, G-protein coupled receptors, receptor 
















Figure A: Mitochondrial Electron Transport Chain generates intracellular ROS. 
Generation of O2.- by complex I, II within the mitochondrial matrix whereas 
complex III can generate O2.- in both intermembrane space and the matrix.  
























Figure B: Activation of NAD(P)H oxidase by several factors leads to the 
generation of intracellular ROS which in turn influence signaling molecules. 












1.7b Cell antioxidant defenses in redox homeostasis 
1.7b (i) Scavenging O2.-  
The level of intracellular ROS is tightly regulated by several antioxidant enzymes.  
In eukaryotic cells, the level of O2.- is controlled by two main scavenger enzymes  
namely Cu/Zn SOD and Mn SOD (Hassan 1988). Cu/Zn SOD is located primarily 
in the cytosol as well as in nucleus, lysosomes and mitochondrial intermembrane 
space and catalyses the conversion of O2.- to H2O2 (Halliwell and Gutteridge 
2007). Mn SOD is expressed mainly in the mitochondria but unlike Cu/Zn SOD, it 
is not inhibited by diethyldithiocarbamate (DDC) (Halliwell and Gutteridge 1999). 
Both Cu/Zn and Mn SOD perform essentially the same catalytic dismutation of 
O2.- to H2O2. 
1.7b (ii) Scavenging H2O2 
The increase in intracellular H2O2 occurs after O2.- dismutation. Two types of 
enzymes are involved in its removal, catalase and glutathione peroxidase. 
Catalase, a tetramer-containing an iron heme group, is largely found in the 
peroxisomes and converts H2O2 into H2O and O2. The other enzyme, glutathione 
peroxidase, tetramer-containing selenium, removes H2O2 by coupling its reduction 
to H2O and oxidation of glutathione (GSH) to GSSG (Halliwell and Gutteridge 
2007). The production of H2O2 in the mitochondria, endoplasmic reticulum or 
cytosol is primarily dealt with by glutathione peroxidase (Chance et al. 1979). If 
the H2O2 diffuses into the peroxisomes, then it will be dealt by catalase (Halliwell 
and Gutteridge 2007). 
1.7c A mild pro-oxidant state promotes cell proliferation 
There is substantial evidence to suggest that low levels of ROS are involved in 
cell proliferation, which has consequently resulted in a paradigm shift that ROS 
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are not solely equated to cell and tissue injury or death. A slight increase in O2.- or 
H2O2 resulted in the activation of tyrosine kinase activity (Heffetz et al. 1990), 
mitogen activated protein kinase like ERK and JNK as well as the transcription 
factors NFκB and AP1 (Droge 2002) – key players in maintaining cell 
proliferation. Similarly, an increase in O2.- or low levels of H2O2 (Droge 2002) 
stimulated IL-2 promoter activity as well as the transcription and expression of IL-
2 receptor (Droge 2002), thereby amplifying T cell activation in an immune 
response. An increase in ROS influenced the activities of several ion channels 
such as IP3 receptor-mediated Ca2+ mobilization, Na+/Ca2+ and NHE membrane 
transporters (Burdon 1995; Sauer et al. 2001). The outcome was stimulation in 
cell growth mediated by the increased activity of these transporters and the 
enhanced activity of NHE culminated in alkaline pH that was conducive to cell 
division (Shibanuma et al. 1988). Moreover, tumor cells are known to have a 
higher level of ROS compared to non-transformed phenotypes (Burdon et al. 
1989; Burdon 1996). This pro-oxidant state and the onset of tumorigenesis are 
corroborated by the ability of O2.- to promote cellular transformation accompanied 
by a low expression of tumor suppressor MnSOD (Oberley 2001; Zhao et al. 
2001; Darby Weydert et al. 2003; Weydert et al. 2003). Along the same lines, 
Irani et al showed that oncoprotein p21Ras activated GTPase Rac1, thus eliciting 
O2.- production, which drove fibroblasts proliferation (Irani et al. 1997). Cancer 
cells expressing the active form of Rac (RacV12) had a higher level of O2.- which 
correlated with resistance to drug-induced apoptosis. Overexpressing the 
dominant negative form of Rac1, RacN17, suppressed the level of O2.- as well as 
sensitized tumor cells to drug-induced apoptosis (Pervaiz et al. 2001).  
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1.7d Ratio of O2.- and H2O2 level dictates the cell’s fate 
It is now becoming obvious that intracellular ROS is involved in regulation of cell 
signaling and that only an overwhelming level of ROS is associated with chronic 
oxidative stress that causes cell necrosis (Majno and Joris 1995). Emerging 
evidence about the divergent intracellular signaling induced by O2.- and H2O2 
indicates that the former is dictating a pro-survival route while the latter is 
favoring apoptotic cell death (Pervaiz et al. 1999). 
Overexpression of Cu/Zn SOD in human melanoma cell line (M14) decreased the 
level of O2.- and heightened the sensitivity of the tumor cells to anti-cancer drugs 
(Pervaiz et al. 1999). Conversely, inhibiting Cu/Zn SOD expression or exposure to 
the SOD inhibitor DDC, created an elevated level of O2.- and precluded apoptosis 
(Clement and Stamenkovic 1996; Pervaiz et al. 1999). Using a different model of 
viral-inducing cell death, a slight surge of O2.- was linked to cell survival while its 
decrease enhanced cell death (Lin et al. 1999). While O2.- is regarded as a pro-
survival signal (Clement et al. 1998b; Clement and Pervaiz 1999; Clement and 
Pervaiz 2001), H2O2 is treated as an inducer of apoptosis (Hampton and Orrenius 
1997; Clement et al. 1998b). At H2O2 doses <500 mM, O2.- level is lowered, the 
ratio of reduced to oxidized glutathione increases, cytosolic pH drops, creating an 
intracellular milieu conducive for apoptotic cell death (Clement et al. 1998a). It 
has to be pointed out that using excessive H2O2 doses will drive necrotic cell death 
by creating chronic oxidative stress (Clement et al. 1998b). Given that generation 
of intracellular H2O2 is a common feature of anti-cancer drug-induced apoptosis, it 
is believed to originate from the mitochondria (Hirpara et al. 2001). Consequently, 
it can diffuse into the cytosol or induce oxidative changes in mitochondrial lipids 
such as cardiolipins (Reed and Kroemer 2000), thus resulting in mitochondrial 
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permeability and the efflux of pro-apoptotic factors such as cytochrome c, 
Smac/DIABLO and apoptosis inducing factor (Reed and Kroemer 2000). 
As discussed so far, the subtle balance of O2.- and H2O2 drives the cell’s fate. The 
inhibitory action of O2.- on cell death could be due to its antagonizing effect on 
caspase activation (Nicholson et al. 1995). In contrast, an increase in intracellular 
H2O2 was shown to stimulate caspase-3 and -9 (Yamakawa et al. 2000; Mannick 
et al. 1999; Pervaiz et al. 1999). Alternatively, during drug-induced apoptosis, 
production of intracellular H2O2 was shown to cause a drop in cytosolic pH 
(Clement et al. 2003). Moreover, drug-induced H2O2 production enabled Bax 
translocation to the mitochondria which was dependent on an intracellular acidic 
environment (Ahmad et al. 2004b). 
1.8 Sodium-hydrogen Exchanger 1 (NHE1) 
1.8a Intracellular pH regulators 
Maintaining the right intracellular pH is pivotal for the proper functioning of 
cellular processes including cell metabolism, Ca2+ homeostasis (Busa and 
Nuccitelli 1984), gene expression (Isfort et al. 1993), cell motility (Orchard and 
Kentish 1990) and cell death (Gottlieb et al. 1996; McConkey and Orrenius 1996). 
Most mammalian cells display a steady intracellular pH (pHi) of 7.1-7.2. 
Considering the thermodynamics and resting membrane potential of a cardiac cell 
being -80mV predicts an intracellular pH of 6.1 using the Nernst Equation (Puceat 
1999). However, the cell is endowed with pH regulators such as proton pumps (H+ 
ATPases) (Al-Awqati 1986), proton channels and ion transporters that transport 
H+ and HCO3- to maintain the pHi at 7.1. The latter group comprises Na+/H+ 
antiport (Murer et al. 1976), Na+-dependent HCO3- transporters (Cremaschi et al. 
1979), Na+-independent Cl-/HCO3- exchanger (Russell and Boron 1976; Kopito 
 22
and Lodish 1985), Cl-/OH- exchanger (Leem and Vaughan-Jones 1998) and 
lactate-proton cotransporter (Rosenberg et al. 1993) (Figure C). Under normal 
physiological settings, cellular metabolism generates an intracellular acid load 
which is mainly dealt with by the NHE exchanger family which mediates the 
electroneutral exchange of a Na+ ion for an H+ ion (Malo and Fliegel 2006). To 
date, 9 isoforms of NHE have been identified (NHE1-9), each with a unique tissue 
and cellular distribution (Malo and Fliegel 2006).  
1.8b The Na+/H+ exchanger family 
In 1976, Murer et al identified a “Na+/H+ exchange system” that played a vital role 
in regulating pHi (Murer et al. 1976). The biochemical characteristics of that 
system showed an influx of Na+ ion for the efflux of H+ ion with a stoichiometry 
1:1. In 1984, the generation of a cell line deficient in Na+/H+ exchange activity by 
Pouyssegur et al proved to be useful in studying the actual role of Na+/H+ 
exchanger (Pouyssegur et al. 1984). The first Na+/H+ exchanger isoform, NHE1, 
was cloned in 1989 and the amino acid sequence was determined from the cDNA 
sequence (Sardet et al. 1989). NHE1 is ubiquitously expressed in all mammalian 
cells and is referred to as the “housekeeping” isoform. The cellular localization of 
NHE1 varies according to the cell type. In fibroblasts, it is located in the 
lamellipodia (Denker et al. 2000; Denker and Barber 2002); in myocardial tissue it 
is concentrated in the intercalated disks and along the transverse tubular system 
(Petrecca et al. 1999) and in epithelial cells, it is found along the basolateral 
membranes (Biemesderfer et al. 1992; Orlowski and Grinstein 2004). The roles of 
NHE1 encompass regulation of pHi, cell volume, migration, survival and death 







Figure C: Regulators of intracellular pH  
NBC: Na+-dependent HCO3- cotransporter; NHE: Na+-H+ exchanger; AE: Anion 
exchanger; CHE: Cl-/OH- exchanger 









meaningful contribution in cancer cell invasion and heart failure (Harguindey et 
al. 2005; Karmazyn et al. 2005). 
NHE2, an apical membrane protein, has a 42% amino acid sequence homology 
with NHE1 (Wang et al. 1993). NHE2 is expressed in the epithelial tissue of the 
intestinal tract (mainly the jejunum, ileum, colon (Bookstein et al. 1997)), kidney, 
skeletal muscle and testis (Malakooti et al. 1999). NHE2 is believed to be 
important in several secretory processes (Malo and Fliegel 2006). However, the 
use of Nhe2-/- mouse showed that NHE2 was not involved in acid secretion in the 
parietal cells of the gastric epithelium (Schultheis et al. 1998). NHE3 and NHE4 
have 39% and 42% amino acid sequence homology with NHE1 (Orlowski et al. 
1992). Both NHE3 and NHE4 exhibit strong expression in the kidney and 
gastrointestinal tract. In renal tissue, NHE3 is an apical membrane protein in the 
proximal tubules and thick ascending limb (Amemiya et al. 1995) while NHE4 
has basolateral epithelial presence and is found mainly in the inner medulla of the 
kidney (Bookstein et al. 1997; Pizzonia et al. 1998). In the gastrointestinal tract, 
NHE3 is found predominantly in the intestine whereas NHE4 is present mainly in 
the stomach. It has recently been found that both NHE3 and NHE4 are present in 
the submandibular gland in rats with NHE3 expressed in the apical side on the 
duct cells whereas NHE4 showing basolateral expression in acinar and duct cells 
(Oehlke et al. 2006). Mouse knockout models of NHE3 and NHE4 highlight the 
fact that NHE3 is the major absorptive Na+/H+ exchanger in the kidney and 
intestine. On the other hand, NHE4 is essential in the regulation of gastric acid 
secretion (Nakamura et al. 1999; Gawenis et al. 2005). 
NHE5 has 39% amino acid identity with NHE1 and 53% with NHE3. Studies on 
NHE5 revealed its restricted expression in brains of rats and humans (Attaphitaya 
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et al. 1999; Baird et al. 1999). NHE5 is thought to be involved in ion homeostasis 
as well as cell-volume regulation and it has been show that Receptor for Activated 
C-kinase 1 (RACK1) directly binds to NHE5 and positively regulates its activity 
(Onishi et al. 2007).  
NHE6-9 are located in the membranes of Golgi and post-Golgi endocytic 
compartments while NHE1-5 are found in the plasma membranes of cells. NHE6 
is found primarily in early recycling endosomes, NHE7 in the trans-Golgi 
network, NHE8 in the mid- to trans-Golgi and NHE9 in the late recycling 
endosomes. It is possible that they regulate the intracellular pH of these organelles 
(Nakamura et al. 2005). 
1.8c Structural features of NHE1 
Based on human NHE1 cDNA, it is predicted that NHE1 consists of 815 amino 
acids. The initial 500 residues are adjudged to form 12 transmembrane (TM)-
spanning segments and the remaining 315 residues to constitute an intracellular 
regulatory domain (Figure D) (Sardet et al. 1989) – a fact confirmed via cysteine-
accessibility analysis by Wakabayashi et al (Wakabayashi et al. 2000). The model 
of Wakabayashi also revealed 1 extracellular and 2 intracellular membrane-
associated loops and more conclusively identified the amino acids in each TM-
spanning segment (Wakabayashi et al. 2000).  
TM-IV is the only region of NHE1 whose structure has been determined using 
nuclear magnetic resonance (NMR). TM-IV is believed to start with a series of β-
turns followed by an extended region and ends as a helix (Slepkov et al. 2005). 
Further studies on the membrane domain revealed its role in the formation of 
NHE1 quaternary structure. NHE1 forms isoform-specific homodimers in vivo 
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with the individual dimer subunits functioning independently of each other 
(Fliegel et al. 1993; Fafournoux et al. 1994). 
The C-terminal structure of NHE1 was determined by circular dichroism (CD). 
The 315 amino acids of the C-terminal end of human NHE1 were expressed in 
E.Coli and purified. They were found to be 35% α-helix, 16% β-turns, 49% 
random coil (Gebreselassie et al. 1998). According to CD, the membrane proximal 
end of the tail structure was predicted as more compact and structured, 
presumably helping to interact with the membrane. The distal end was more 
flexible, possibly to enable structural changes associated with phosphorylation 
events and protein interactions (Gebreselassie et al. 1998; Li et al. 2003a). 
1.8d Regulation of NHE1  
NHE1 is known to be regulated both on a short-term (the activity of the 
exchanger) and a long-term basis (regulation of gene expression). The long C-
terminal end of NHE1 is considered to be responsible for the activity of the 
antiporter as a result of binding to cofactors and/or undergoing phosphorylating 
events and is involved in the short-term regulation (Zachos et al. 2005). The long-
term regulation involves NHE1 gene expression by several transcription factors 
(Zachos et al. 2005). 
1.8d (i) Role of cofactors 
1.8d (i)-1 Phosphatidylinositol-4,5-bisphosphate (PIP2) 
PIP2 is a signaling phospholipid found in eukaryotic plasma membrane. Following 
specific stimuli, PIP2 can be converted to inositol-1,4,5-triphosphate (IP3) and 










Figure D: Topological representation of NHE1. Amino acids essential in transport 
and/or inhibitor efficacy are indicated. On the C-terminal end, binding sites of 
calcineurin homolog protein (CHP), calmodulin (CaM) are shown.  








The amount of cellular PIP2 is dependent on the level of ATP which consequently 
has an effect on NHE activity (Suh and Hille 2005). Although NHE1 activity does 
not consume ATP, NHE1 dependence on ATP has been found to be associated 
with cellular PIP2 level. As a result of ATP depletion, cellular PIP2 level decreases 
and so does NHE1 activity (Aharonovitz et al. 2000). NHE1 has 2 PIP2 binding 
sites, amino acids 513-520 and 556-564. Mutation of both sites inhibits NHE1 
activity. Besides, PIP2 has been shown to bind the C-terminal end of NHE1 in 
vitro (Aharonovitz et al. 2000).   
1.8d (i)-2 Role of Ca2+ in the regulation of NHE1 activity 
1.8d (i)-2A Calcineurin homologous protein (CHP) 
Three isoforms of CHP are known to exist. CHP1 is known to be ubiquitously 
present in almost all tissues; CHP2 is restricted to cancer cells and the intestinal 
tissues while CHP3 has been identified in the brain, heart, testis and stomach. 
Only CHP1 and CHP2 were shown to regulate NHE1 activity (Pang et al. 2001; 
Pang et al. 2004; Ben Ammar et al. 2006). 
Following the screening of an expression library with the C-terminal domain of 
NHE1, CHP1 was identified as being an NHE1 binding protein (Lin and Barber 
1996). It was found to interact with the hydrophobic region of residues between 
amino acids 510-530 of NHE1 cytoplasmic domain. NHE1 or CHP1 mutants 
espouse the hypothesis that NHE1-CHP1 interaction is essential for NHE1 activity 
as the mutants demonstrate dramatic reduction in NHE1 activity (Pang et al. 
2001). The characterization of NHE1-CHP1 binding suggested the involvement of 
a Ca2+ -dependent, high-affinity interaction (Pang et al. 2004). Indeed CHP1 has 4 
EF motifs that bind Ca2+ but EF3 and EF4 seem to be critical in coordinating the 
effects of Ca2+ on NHE1 activity. Mutating either EF3 or EF4 compromised 
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NHE1 activity whereas mutation of both impaired the interaction of CHP1 with 
NHE1 (Pang et al. 2004). 
The crystal structure of CHP2 binding to NHE1 has been studied (Ben Ammar et 
al. 2006). Residues in the N- and C-lobes of CHP2 form a hydrophobic cleft in 
which the α-helical CHP-binding region of NHE1 is inserted via hydrophobic 
interaction and hydrogen bond formation. Mutational analysis highlighted the 
critical role of Ile534 and Ile537 of NHE1 in its association with CHP2. Mutation 
of these two residues disrupted NHE1 function resulting in a significant decrease 
in maximal exchange activity and a major acidic shift in the pHi-dependence of 
exchange (Ben Ammar et al. 2006). 
1.8d (i)-2B Calmodulin (CaM) 
Calmodulin is Ca2+ binding protein that regulates NHE1 activity in response to 
Ca2+ signaling. After binding Ca2+, CaM binds to NHE1 at 2 different cytoplasmic 
domains with contrasting binding affinities. Residues 636-656 constitute a high 
binding affinity zone for CaM while residues 657-700 present a low binding 
affinity area (Bertrand et al. 1994). In the absence of CaM and Ca2+, the high 
binding affinity site binds to another region of NHE1, generating an auto-
inhibitory effect (Wakabayashi et al. 1997). Residues Leu639, Lys651, Tyr652 are 
important in this interaction. The presence of CaM and Ca2+ preclude this 
interaction and activate NHE1 function (Bertrand et al. 1994). 
1.8d (i)-2C Tescalcin 
Tescalcin is another Ca2+ binding protein, structurally homologous to CHP. Upon 
binding to Ca2+, tescalcin interacts with NHE1 C-terminal end and inhibits NHE1 
activity (Mailander et al. 2001; Li et al. 2003a). The site of interaction of tescalcin 
was reported to be different from CaM (Mailander et al. 2001; Li et al. 2003a). 
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1.8d (ii) Role of phosphorylation events on NHE1 activity 
The activation of NHE1 via phosphorylation of its carboxy-terminal was shown 
using serum growth factors and phorbol esters. Residues 636-815 were found to 
play a significant role in coordinating the activation of NHE1 by phosphorylation; 
removal of these residues repressed the activity of NHE1 by 50% in the presence 
of serum growth factors (Wakabayashi et al. 1994). Ca2+/calmodulin dependent 
protein kinase II (CaM kinase II) was the first kinase shown to phosphorylate 
NHE1 in vitro (Fliegel et al. 1992). However, neither protein kinase C (PKC) nor 
protein kinase A (PKA) was found to phosphorylate the last 178 residues in vitro 
(Fliegel et al. 1992). The mitogen-activated protein kinase (MAPK) also known as 
extracellular-regulated kinases 1 and 2 (ERK1/2) were found to activate NHE1 by 
phosphorylating the C-terminal end (Bianchini et al. 1997). Inhibiting ERK 
signaling cascade resulted in 50-60% decrease in growth factor stimulation of 
NHE1 activity in Chinese hamster fibroblasts cells (Bianchini et al. 1997). 
ERK1/2 can be activated by serum, thrombin, epidermal growth factor, insulin 
and angiotensin II. It is well documented that p90RSK, a downstream target of 
ERK1/2, is involved in phosphorylating NHE1 and activating it (Phan et al. 1997). 
An interesting fact about the modulation of NHE1 activity by p90RSK is that after 
phosphorylating Ser703 (Takahashi et al. 1999), it induces the formation of 14-3-3 
ligand binding site. The binding of 14-3-3 to the phospho-Ser703 prevents 
dephosphorylation and culminates in serum-induced NHE1 activation (Lehoux et 
al. 2001). The novel inhibitor for RSK called fmk was further shown to inhibit α-
adrenergic stimulation of NHE1 phosphorylation. Consequently, NHE1 activity 
was impaired (Cuello et al. 2007). 
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Since the role of several kinases on NHE1 activity has been elucidated, Misik et al 
addressed the role of phosphatases on NHE1 activity (Misik et al. 2005). When 
primary cultures of cardiomyocytes were treated with the phosphatase inhibitor, 
okadaic acid, there was a significant increase in the rate of recovery after an acid 
load, thus highlighting the importance of PP1 in regulating NHE1 activity in vivo. 
Using purified PP1, PP2A and PP2B showed significant dephosphorylation of 
NHE1 by PP1, poor dephosphorylation by PP2A and no dephosphorylation by 
PP2B. Overexpression of PP1 in cell lines caused a decrease in NHE1 activity. 
Conversely, the cell lines that express the specific PP1 inhibitor, inhibitor 2, had 
increased proton efflux rates which was not further increased by the agonist, 
thrombin. These findings pointed to the importance of PP1 in regulating NHE1 
activity (Misik et al. 2005). 
1.8d (iii) Intracellular acidosis increases NHE1 activity 
NHE1 activity is greatly enhanced following a decrease in intracellular pH 
(Karmazyn et al. 2001). This activation has a Hill coefficient of about 3, 
demonstrating that more than one proton is involved in the transport to the 
extracellular space (Avkiran and Howard. 2003). Sustained intracellular acidosis 
was shown to increase NHE1 activity in neonatal rat ventricular myocytes 
(Haworth et al. 2003). Similar findings were recorded in adult ventricular 
myocytes and the monkey COS-7 non-myocyte cell line (Haworth et al. 2003).   
1.8d (iv) Regulation of NHE1 gene expression 
NHE1 gene is located on chromosome 1, p36-p35, in humans and is 
approximately 70 kilobases long. In mice and rats, NHE1 is located on 
chromosome 4 and 5 respectively. The human NHE1 coding region is divided into 
12 exons and 11 introns. The promoter/enhancer region is made up of a TATA 
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box, 4 GC boxes, 2 CAAT boxes, 3 AP-1 sites and a cAMP response element 
(Miller et al. 1991). Regulation of NHE1 gene expression has been widely 
investigated. Mitogenic stimulation of NHE1 promoter activity is linked to an 
increase in NHE1 gene transcription and protein expression (Besson et al. 1998). 
Analysis of the NHE1 promoter revealed several important regions that harbor 
specific transcription factors that are critical in NHE1 gene regulation. 
Transcription factor AP2 or an AP2-like protein was shown to be responsible for 
NHE1 gene regulation during P19 cellular differentiation (Dyck and Fliegel 1995) 
(Figure E). The AP2 transcription factor family is composed of five related factors 
AP2α, AP2β, AP2γ, AP2δ and AP2ε. These AP2 factors are known to play 
important roles in apoptosis, cell growth and tissue differentiation during 
embryogenesis (Hilger-Eversheim et al. 2000). In addition, AP2 has been 
described as a tumor survival gene (Turner et al. 1998) as well as a tumor 
suppressor gene (Gee et al. 1999). Other regions along the NHE1 promoter were 
shown to bind specific proteins from nuclear extracts according to DNA foot-
printing experiments. Among these transcription factors are the AP1, AP2 and 
C/EBP proteins (Miller et al. 1991; Kolyada et al. 1994; Dyck and Fliegel 1995). 
Besides, a highly conserved poly (dA:dT)-rich region was found to regulate NHE1 
gene expression (Yang et al. 1996a). Chicken ovalbumin upstream promoter- 
transcription factor (COUP-TF) which are orphan receptors involved in 
embryonic development and neuronal cell death have been implicated in NHE1 
gene regulation through a nuclear hormone responsive element in NIH3T3 and L6 





















Figure E: Schematic diagram of the nucleotide sequence of the proximal 1.1kb of 
the NHE1 promoter-enhancer region including the AP2 binding site. 






Additional studies have emphasized a positive correlation between thyroid 
hormone levels and NHE1 gene expression, that is, increasing the amount of 
circulating thyroid hormone brings about an increase in NHE1 mRNA and protein 
(Slepkov and Fliegel 2004). Further evidence has shown that NHE1 promoter 
contains a thyroid receptor (TR)-α1 binding site. 
1.9 Pathophysiological functions of NHE1 
1.9a Cell proliferation and cell survival 
A number of studies have investigated the physiological relevance of NHE1 
(Figure F). Using Chinese hamster lung fibroblasts cells (CCL39) which are 
deficient in NHE1, it was found that they lacked the ability to grow at neutral and 
acidic pH (Pouyssegur et al. 1984). Using Nhe1-/- knockout mice showed a 
decreased rate of post-natal growth and exhibited ataxia and epileptic-like seizures 
(Cox et al. 1997; Bell et al. 1999). Furthermore, activated NHE1 leads to an 
alkaline pHi which promotes the timely transition of cells from S phase to the 
G2/M phase. A defective NHE1 showed a delay in S phase and mitosis is stalled 
(Putney and Barber 2003). All these evidences point to the importance of NHE1 in 
regulating cell growth and proliferation. 
Cytoskeletal anchoring by NHE1 was found to be important in enhancing cell 
survival. Using mutant NHE1 that independently lack ion translocating ability or 
ERM binding capacity, Wu et al showed that both characteristics conferred 
protection to NHE-deficient fibroblasts and renal epithelial cells against apoptosis 
(Wu et al. 2003; Wu et al. 2004).  This interaction of NHE1 with the ERM 
proteins resulted in activation of the prosurvival kinase, Akt and thus apoptosis is 
inhibited (Wu et al. 2004). 
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1.9b Cell migration and cell volume 
NHE1 is anchored to the cytoskeleton via the actin binding proteins ezrin, radixin, 
moesin (ERM) and is involved in the maintenance of cytoskeletal structure, focal 
adhesion and cell migration (Denker et al. 2000). NHE1 deficient cells have 
disrupted focal adhesion and cells which express NHE1 but cannot interact with 
the ERM proteins have diminished actin stress fiber organization, irregular cell 
shape and defective cell migration (Tominaga and Barber 1998; Denker et al. 
2000; Denker and Barber 2002). 
Besides, the exposure of cells to hypertonic solution induces cell shrinkage. This 
is counteracted by the influx of Na+ and Cl- accompanied by water and a 
compensatory cell swelling – a process coined as regulatory volume increase 
(RVI). During RVI, Na+ ions are driven intracellularly in exchange for protons 
and the process is controlled by the NHE proteins. In some cases, the influx of 
Na+ ions in response to hypertonicity occurs as a result of cotransport with K+ and 
Cl- ions via the sodium-potassium-two chloride cotransporter (NKCC). The net 
uptake of Na+ ions is to reinstate intracellular volume in the advent of cell 
shrinkage (Lang et al. 1998a; Lang et al. 1998b; Waldegger et al. 1998). The 
importance of NHE1 in RVI has been proven from mutants lacking NHE1 which 
failed to regain volume after imposed shrinkage (Grinstein et al. 1992; Kapus et 
al. 1994). 
1.9c Cell injury during ischemia and reperfusion 
In cardiomyocyte sarcolemma, NHE1 is the predominant isoform. It is responsible 
for maintaining the pHi homeostasis and contractility since 50% of proton efflux 
in isolated perfused ferret hearts was due to NHE1 (Grace et al. 1993). 
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During ischemia, anaerobic glycolysis results in an increase in lactate and protons, 
thereby activating NHE1. The increase in intracellular Na+ ions (Lazdunski et al. 
1985; Avkiran 2001; Allen and Xiao 2003) leads to an increase in Ca2+ ions via 
the reversal of the Na+/Ca2+ exchanger. An intracellular buildup of Ca2+ stimulates 
the activation of several pathways that converge to cell death. Inhibitors of NHE1 
such as cariporide, amiloride and EMD 85131 confer a protective shield to the 
myocardium against Ca2+ overload during ischemia and reperfusion (Karmazyn 
1988; Scholz et al. 1995; Gumina et al. 1998). It was recently shown that by 
inhibiting p90RSK, NHE1-mediated cardiac ischemia-reperfusion injury was 
prevented (Maekawa et al. 2006). Moreover, following in vitro ischemia, ERK1/2-
p90RSK pathway was activated that led to the activation of NHE1 and neuronal cell 
death (Luo et al. 2007). 
However, the GUARd During Ischemia Against Necrosis (GUARDIAN) study 
which covered several clinical situations reported the inefficacy of cariporide 
(Theroux et al. 2000). Similar findings were recorded from the Evaluation of the 
Safety and Cardioprotective effects of eniporide in Acute Myocardial Infarction 
(ESCAMI) (Zeymer et al. 2001). Nevertheless, more research needs to be 
undertaken to confirm the role of NHE1 in the development of reperfusion injury. 
1.9d NHE1 in tumorigenesis 
A biochemical hallmark of tumor cells is that their intracellular pH is alkaline 
compared to their normal counterparts (7.12-7.65 compared to 6.99-7.20). It has 
been shown that NHE1 is implicated in the altered pHi of malignant cells. 
Besides, NHE1-dependent alkalinization plays a fundamental role in malignant 
transformation as inhibition of NHE1 activity precludes it (McLean et al. 2000; 
Reshkin et al. 2000b; Rich et al. 2000). In normal cells, serum activates NHE1 
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activity whereas in breast cancer cells, serum deprivation is found to stimulate 
NHE1 activity leading to cell motility and invasiveness (Reshkin et al. 2000a). 
Pseudopodia formation correlates with an increase in NHE1 activity which if 
inhibited, reduces tumor invasiveness (Lagana et al. 2000). The cytoskeletal 
rearrangement responsible for pseudopodia formation involved RhoA 
phosphorylation and inhibition by PKA which stops p160ROCK activation 
(Cardone et al. 2005). This in turn obviates p38-mediated inhibition of NHE1 
activity and promotes tumor invasiveness (Paradiso et al. 2004; Cardone et al. 
2005).  
1.9e Regulation of cell sensitivity to death trigger: a function of NHE1 
A decrease in O2.- concomitant with a slight increase in H2O2 level creates an 
intracellular acidic milieu – a phenomenon often observed in drug or receptor-
induced apoptosis (Matsuyama et al. 2000; Clement et al. 2003). A drop in 
cytosolic pH could be due to the increase in PARP activity thus paving the way 
for a decrease of NADH and ATP stores and culminating in the repression of 
intracellular pH regulators, notably Na+/H+ exchanger family of proteins (Hirpara 
et al. 2001). 
Interestingly, recent reports highlighted the role of ROS in modulating NHE1 
gene expression. For example, a slight increase in O2.- stimulated NHE1 promoter 
activity and protein expression (Akram et al. 2006). In contrast, an elevation of 
H2O2 inhibited NHE1 promoter activity and protein expression (Akram et al. 
2006; Kumar et al. 2007). These findings provided new insights in NHE1 gene 
regulation whereby down-regulation of NHE1 expression was associated with an 
increase in cells’ sensitivity to cell death triggers. 
 
 38
1.9f NHE1 activity regulate the expression profiles of genes  
A global profiling of gene expression was carried out using LAPE (containing 
mutant NHE1 with a defect in its ion translocating ability) and LAPN (containing 
wild-type NHE1) muscle fibroblasts (Putney and Barber 2004). A number of 
genes involved in growth factor signaling, cell cycle progression, cytoskeleton and 
extracellular matrix remodeling were found to correspond to the role of NHE1 and 
intracellular pH with respect to mitogenic responses, cell proliferation and tumor 
metastasis (Putney and Barber 2004). Intrestingly, novel findings were attributed 
to the potential functions of NHE1 regarding carbohydrate metabolism (Putney 
and Barber 2004).  
Hexokinase, phosphofructose kinase, pyruvate kinase were all upregulated in 
LAPE cells as opposed to LAPN cells. In LAPE cells, a decrease in citrate in the 
cytosol would lead to an increase in the activity of phosphofructose kinase 
(Putney and Barber 2004). This in turn would stimulate the glycolytic flux and 
production of lactic acid (Dang et al. 1997). Increase in intracellular acidosis will 
increase NHE1 activity (Reshkin et al. 2000) and this could trigger the 
















Figure F: Pathophysiological functions of NHE1. (A) Regulation of pHi and cell 
volume. (B) Hormone activation of NHE1 leads to cell growth and proliferation 
and in myocardium it can lead to hypertrophy. (C) Ischemia activates NHE1 
leading to Na+/Ca2+ exchanger activation culminating in cell injury. (D) NHE1 
found in lamellipodia is regulated by ERM proteins and hence mediate cell 
migration.  
Taken from Fliegel L, 2005, The International Journal of Biochemistry & Cell 




1.10 Aim and objectives 
RSV has a plethora of benefits in various disease models (Pervaiz and Clement 
2004). The various biological activities of RSV are attributed to its antioxidant 
potential (Kawada et al. 1998), inhibition of cell proliferation (Bhat and Pezzuto 
2002; Joe et al. 2002) and targeting of transcriptional machinery (Manna et al. 
2000; Ashikawa et al. 2002). However, recent studies have unravelled that RSV 
can elicit either an anti- or pro-oxidant intracellular milieu in cell culture models 
(Ahmad et al. 2004a). Alterations in redox cellular status have been implicated in 
several physiological and pathological states leading to cell death and cell 
survival. To that end, a fine balance between the level of intracellular H2O2 and 
O2.- regulates cell sensitivity to death stimuli (Clement and Stamenkovic 1996; 
Clement and Pervaiz 1999; Clement and Pervaiz 2001; Pervaiz and Clement 2002; 
Clement et al. 2003; Pervaiz and Clement 2004). Addition of exogenous H2O2 to 
colorectal carcinoma (HCT116) or its intracellular production translocates Bax to 
the mitochondria in a pH-dependent manner during apoptosis (Ahmad et al. 
2004b). To further corroborate the interplay between redox regulation of cell 
death/survival and intracellular pH, NHE1 has been shown to be a critical target of 
intracellular ROS (Pervaiz and Clement 2002). An increase in intracellular O2.-
increases NHE1 promoter activity and protein expression whereas addition of 
exogenous H2O2 represses NHE1 promoter activity and protein expression 
(Akram et al. 2006; Kumar et al. 2007).  
Considering the link between death promoting effect of intracellular acidification, 
effect of ROS on NHE1 and RSV affecting NHE1 activity, the aim of this project 
was to investigate the mechanistic role of RSV in regulating NHE1 gene 
expression. This included analyzing the NHE1 promoter activity, mRNA level and 
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protein expression in L61.1kb cells after treatment with RSV. The next goal was 
to investigate whether regulation of NHE1 gene expression by RSV was redox-
regulated and caspase-dependent. Finally, the physiological impact (including 
intracellular pH and cell cycle analysis) after alteration of NHE1 gene expression 




















Chapter 2. Materials and Methods 
2.1. Chemicals and Reagents 
Resveratrol, crystal violet, dimethyl sulfoxide (DMSO), dimethylthiourea 
(DMTU), the protease inhibitors phenylmethylsulfonyl fluoride (PMSF), 
leupeptin, pepstatin, aprotinin, the phosphatase inhibitor sodium vanadate, 
lucigenin and 1x somatic cell ATP releasing agent were purchased from Sigma-
Aldrich. Resveratrol was reconstituted in DMSO at a final concentration of 200 
mM.  
Caspase-3 tetra-peptide inhibitor (Z-DEVD-FMK), caspase-6 tetra-peptide 
inhibitor (Z-VEID-FMK) and the pan-caspase inhibitor (Z-VAD-FMK) were 
supplied by R&D Systems (MN, USA). Caspase-3 substrate (Ac-DEVD-AFC), 
caspase-6 substrate (Ac-VEID-AFC), caspase-8 substrate (Ac-LETD-AFC) and 
caspase-9 (Ac-LEHD-AFC) substrate were purchased from Alexis Biochemicals 
(Lausen, Switzerland). 
NHE1 antibody was purchased from Chemicon International Inc (CA, USA). Β-
actin antibody was supplied by Sigma-Aldrich (MO, USA). Caspase-3, caspase-6 
and AP-2α antibodies were bought from Cell Signalling Technology (MA, USA). 
Catalase antibody was obtained from Calbiochem Biochemicals (Darmsdadt, 
Germany). 
Cell culture medium used included Dulbecco’s modified Eagle's medium 
(DMEM) and Roswell Park Memorial Institute (RPMI), both purchased from 
Hyclone (CA, USA). Fetal bovine serum (FBS) was obtained from Hyclone while 




2.2. Cell lines and reporter plasmid constructs 
All the cell lines used in this project were adherent ones. L6, rat myoblast cell 
line, was stably transfected with the following luciferase reporter plasmid 
contructs: pXP-1.1MP (designated L61.1kb), pXP-0.9MP, pXP-0.5MP, pXP-
0.2MP, pXP-0.18MP, pMP+AP2 as well as pMP-AP2 , pMP(Mut)AP2 and empty 
vector pXP1 were kindly provided by Dr. Larry Fliegel, Department of 
Biochemistry, University of Alberta, Canada (Yang et al. 1996). 
The stably transfected L6 cells were maintained in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% FBS, 2 mM L-glutamine, 0.25 mg/ml 
geneticin (Gibco-BRL, MD USA) and 1 mM gentamicin sulfate (BioWhittaker, 
MD, USA). Wild-type L6 cells were maintained as L61.1kb cells except that 
geneticin was not used.  
MEF mouse embryonic fibroblasts and M14 human melanoma cells were 
maintained in DMEM supplemented with 10% FBS, 2 mM L-glutamine and 1 
mM gentamycin sulfate. 
NIH3T3 mouse fibroblast cells, MCF7 and MDA-MB 231 (two breast 
adenocarcinomas) were kept in RPMI medium supplemented with 10% FBS, 2 
mM L-glutamine and 1 mM gentamycin sulfate. T24 cells (human bladder 
carcinoma) were cultured in McCoy’s medium with 10% FBS. NIH3T31A8 
mouse fibroblast cells were stably transfected with the 1.1kb of NHE1 proximal 
promoter upstream of the lucifearse reporter gene and were maintained in 
Minimum Essential Medium (MEM) supplemented with 10% FBS, 2 mM L-




2.3. Crystal violet assay 
Cells were seeded (0.05-0.1 x 106) and grown in 12-well plates (Nuncleon, Nunc, 
Denmark). Cell culture medium was aspirated and cells were washed with 1 ml of 
1x PBS per well. One hundred microlitres of crystal violet solution were added 
per well and incubated for 10 min at 25oC in the dark. Crystal violet solution was 
washed away with distilled water several times. Plates were left to dry overnight. 
Five hundred microlitres of 1x PBS/1% SDS solution was added per well and left 
overnight to ensure complete lysis. Absorbance was then measured at 595nm 
using a plate reader, Tecan SpectraFluor Plus and expressed as OD values 
(595nm). 
2.4. Luciferase reporter assay 
NHE1 promoter activity was assessed with the luciferase reporter assay kit 
(Promega). Cells were seeded (0.05-0.1 x 106) and grown in 12-well plates 
(Nuncleon, Nunc, Denmark). Briefly, feeding medium was washed away and cell 
debris cleared away with 1x PBS before cells were lysed with 100 µl of reporter 
lysis buffer. Ten microlitres of cell lysate was added to 50 µl of luciferase 
substrate solution. Bioluminescence emitted was measured using a Sirius 
luminometer (Berthold). The luminescence readings generated were normalized to 
the protein concentration of the corresponding cell lysate and expressed as 
RLU/µg protein. Protein concentration was determined using the Coomasie Plus 
Protein Assay Reagent Kit (Pierce Chemical Company, Rockford, IL, USA). 
2.5. Cell Morphology 
Cells were seeded (0.2-0.25 x 106) and grown in 6-well plates (Nuncleon, Nunc, 
Denmark). The morphology of the cells was captured using the Nikon digital 
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camera (DXM1200F) attached to the light microscope at 10X objective lens. 
Picture of cells were saved using the software Nikon ACT-1 Version 2.63.   
2.6. Caspase activity assay  
Cells were seeded (0.4-0.45 x 106) and grown in 60 mm dishes (Nuncleon, Nunc, 
Denmark). Cells were lysed using chilled 1x Cell Lysis Buffer (BD Pharmingen, 
CA, USA) and incubated on ice for 10 minutes. Cell lysate was added to equal 
volume of 2X Reaction Buffer (10 mM HEPES, pH7.4, 10 mM KCl, 2 mM 
EDTA, 6 mM DTT and 1.5 mM MgCl2) supplemented with protease inhibitors (1 
mM PMSF, 10 µg/ml pepstatin A, 10 µg/ml aprotinin, 20 µg/ml leupeptin), and 
50 µM caspase substrate (AG Scientific, CA, USA). Samples were incubated at 
37ºC for approximately 1.5 h in the spectrofluorometer and AFC fluorescence 
quantified (excitation wavelength: 400 nm, emission wavelength: 505 nm). 
Caspase activity was standardized to protein amounts and expressed as RFU/µg 
total protein. Protein concentration was determined using the Coomasie Plus 
Protein Assay Reagent Kit (Pierce Chemical Company, Rockford, IL, USA). 
2.7. Flow cytometric analysis of intracellular H2O2 concentration  
Cells were seeded (0.2-0.25 x 106) and grown in 6-well plates (Nuncleon, Nunc, 
Denmark). Intracellular concentration of H2O2 was determined by staining with 
the redox sensitive dye 5-(and-6)-chloromethyl-2V, 7V-dichlorofluorescein 
diacetate (CM-H2DCFDA; Molecular Probes, Eugene, OR), which fluoresces 
under oxidation by H2O2 and its free radical products. Briefly, cells were washed 
once with PBS, treated with 5 µmol/L CM-H2DCFDA at 370C for 15 minutes, and 
analyzed using flow cytometry (Coulter EPICS Elite ESP) at an excitation 
wavelength of 488 nm. 300µM H2O2 was used as positive control. At least 10,000 
events were analyzed. 
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2.8. Cell cycle analysis 
The effect of RSV on the cell-cycle was studied by staining the cells with 
propidium iodide (PI) dye. Cells were seeded (0.2-0.25 x 106) and grown in 6-well 
plates (Nuncleon, Nunc, Denmark). Briefly, cells were scraped off and spun at 
2500 rpm at 40C for 5 mins. One millilitre of cold 1x PBS/1% FBS was used to 
wash the pellet and cells were spun again at 2500 rpm at 40C for 5 min. Pellet was 
resuspended with 100 µl of 1x PBS/1% FBS. Cells were immediately fixed by 
dropwise addition of 1 ml of 75% ethanol while vortexing. Samples could be 
stored at 40C.  
For flow cytometric analysis, samples were spun at 10000 rpm at 40C for 5 min 
and pellet was resuspended with 0.5 ml of 1X PI/RNaseA solution (PI stock 
concentration was 50X and RNase A was 40X) before 30 min incubation at 370C. 
Flow cytometric analysis was carried out at excitation wavelength 488 nm and 
emission wavelength 610 nm. Results were analysed using the WinMDI software 
and cells were gated. 
2.9. RNA isolation and Real-Time PCR  
Cells were seeded (0.4-0.45 x 106) and grown in 60 mm dishes (Nuncleon, Nunc, 
Denmark). Total RNA was isolated from cells by TRIZOL reagent (Invitrogen, 
CA, USA) as described by manufacturer’s instructions including an additional 
DNAse treatment step. Each Reverse Transcription (RT) reaction contains 2.5 µg 
of total RNA, 1X RT buffer, 5 mM MgCl2, 425 µM each of dNTPs, 2 µM random 
hexamers, 0.35 U/µl RNase inhibitor, 1.1 U/µl MultiScribe™ reverse transcriptase 
and made up to 10 µl with diethylpyrocarbonate (DEPC) water. RT reaction was 
carried out at 37oC for 1 h. Five microlitres of the 10 µl cDNA reaction volume 
was used in realtime quantitative PCR using ABI PRISM 7500 (Applied 
 47
Biosystems). Results were normalized to glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) for rat RNA. Fluorescence was measured using the 
Sequence Detection Systems 2.0 software. PCR was carried out in multiplex (both 
target and endogenous control co-amplified in the same reaction) with distinct 
fluorescent dyes. The sequences for primers (300 nM) and probe (200 nM) for rat 
NHE1 used in this study are as follows: rat NHE1,  
Forward (5-TGCCTCATGAAGATAGGTTTCCA-3),  
Reverse (5AGCAGCCCCACTACGATCAG-3) and 
Probe (5-FAM-CACCATCTCAAGCATCGTCC-CGGA-TAMRA-3).  
Primers and probe for rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
(Assays on Demand), rat NHE1 were purchased from Applied Biosystems (CA, 
USA). The purity of the RNA was in the range of 1.7-1.9. 
2.10. Western blot analysis 
Whole cell lysates were prepared with 1X RIPA lysis buffer containing 20 mM 
Tris (pH 7.5), 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 1% NP-40, 
supplemented with 1 mM PMSF, 1 µg/ml pepstatin A, 1 µg/ml leupeptin, 1 µg/ml 
aprotinin and 1 mM Na3VO4 before use. Protein concentration was determined for 
each sample. This was done using the Coomassie Plus – The Better Bradford 
Assay Kit (Pierce Chemical Company, Rockford, IL, USA) and the corresponding 
absorbance was measured at 595 nm using the plate reader, Tecan SpectraFluor 
Plus. Equal amounts of protein were warmed at 37°C in a dry heating block for 
NHE1 protein, with 1x SDS sample buffer (0.313 M Tris-Cl, 10% SDS, 50% 
glycerol, 0.05% bromophenol blue, 0.5M DTT and water) and resolved by 8% 
SDS-PAGE at 120V. The amount of NHE1 proteins loaded was approximately 
60µg. Running buffer was 5X SDS/Glycine electrophoresis buffer (15.1 g/L Tris 
 48
base, 72 g/L glycine, 5 g/L SDS). Proteins were transferred onto nitrocellulose 
membrane at 0.35 A current, followed by blocked for 1 hour at RT with 5% non-
fat milk, and membrane incubated overnight at 4ºC with the primary antibody 
(NHE1 is 1:1000, β-actin is 1:8000). After probing with respective secondary 
antibody (NHE1 is 1:30000, β-actin is 1:100000) for 1 h at 25oC, protein bands 
were detected by using the Supersignal West Pico Chemiluminescence (Pierce, 
Rockford, IL, USA). The loading control used was β-actin antibody.  
For quantification of protein bands, the densitometric software used was Science 
Lab 2005 (Fujifilm). 
2.11. Measurement of intracellular pH and NHE-1 activity 
This technique was derived from the original work of Roos and Boron (Roos and 
Boron 1981). Cells were seeded (0.2-0.25 x 106) and grown in 6-well plates 
(Nuncleon, Nunc, Denmark). Cells were washed and incubated with 5 µM of 
BCECF-AM in HCO3--free HEPES buffer (135 mM NaCl, 5 mM KCl, 1.8 mM 
CaCl2, 1 mM MgSO4, 5.5 mM glucose, 10 mM HEPES and pH 7.4) for 30 min at 
370C. The cells were washed and fluorescence of BCECF was measured 
(excitation at 485 and 430 nm; emission at 535 nm) using the plate reader, Tecan 
SpectraFluor Plus. pHi was derived by determining the ratio of dual excitation 
measurement (485:430 nm) from a pHi standard curve. To calibrate the 
relationship between the excitation ratio (485:430 nm) and pH, cells loaded with 5 
µM BCECF-AM were incubated with 10 mM nigericin for 3 min in high K+ 
buffer of pH 6.4–8.0, obtained by mixing pH 4 buffer (140 mM KH2PO4 and 20 
mM NaCl) and pH 9 buffer (70mM K2HPO4 and 20mM NaCl), and fluorescence 
measurement was taken. After measurement of pHi, the cells were acid loaded 
with HCO3-- free HEPES buffer containing 30 mM NH4Cl, pH 7.4 for 10 min. 
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The cells were then exposed to Na+-free and HCO3--free HEPES buffer (135 mM 
N-methyl glucamine, 5 mM KCl, 1.8 mM CaCl2, 1 mM MgSO4, 5.5 mM glucose, 
10 mM HEPES and pH 7.4) for 30 s and subsequently washed with HEPES 
buffer. The pH recovery from acid load was monitored every 2 min for 30 min 
and NHE-1 activity was determined by the rate of pHi recovery within the first 2 
min and is expressed as δpH/δtime (δpH/δt). 
2.12. Amplification of plasmids 
A small amount of DNA-Glycerol stock (transformed bacterial E.Coli DH5α cells 
kept in -800C freezer) was added to a polypropylene culture tube containing 5 ml 
Luria Broth (pH 7.5) (NUMI, Media Preparation Facility) and 100 µg/ml 
ampicillin. The tubes were left to shake at 370C overnight. The next day, the 
incubated bacterial culture was added to 250 ml Luria Broth (pH 7.5) containing 
100 µg/ml ampicillin and left to shake at 370C overnight. On the following day, 
the plasmid DNA was extracted using the Nucleobond kit (Clontech Laboratories, 
CA, USA). DNA was then purified with high salt and ethanol and dissolved in 
sterile water for storage at -200C. The purity of the plasmids was in the range 1.6 - 
1.8. 
2.13. Transient transfections 
Transient transfections of plasmid DNA and small interfering RNA (siRNA) were 
performed using the CalPhosTM mammalian transfection kit (Clontech 
Laboratories Inc, Palo Alto, CA). siRNA for caspase-3 and caspase-6 were 
purchased from Ambion Inc (Texas, USA). Briefly, 0.2x106 cells or 0.4x106 cells 
were seeded in 6-well plates or 60 mm dishes respectively. Cell culture medium 
was changed to DMEM containing 10% FBS, 2 hours prior to transfection. The 




Solution A Volume (µl) 
Plasmid DNA or siRNA            X 
CaCl2 (2.5 M)         12.4 
Sterile H2O            Y 
Total         100 
 
Solution A was added dropwise to 100 µl of solution B (2x Hepes Buffered 
Saline) with gentle vortexing. The transfection mixture was left to incubate at 
room temperature for 20 min. 
The transfection mixture was added to each well in a dropwise manner. Plates 
were moved gently back and forth to ensure homogenous distribution of the 
plasmids/siRNA. Following 12-14 hours of incubation, cells were washed with 1x 
PBS twice and replaced with fresh medium. Cells were then harvested after 24 
hours for relevant assays. Transfection efficiency using this method is purported 
to be around 30%. 
2.14. Amplex Red H2O2/Peroxidase assay 
To determine whether RSV induced exogenous H2O2 production in DMEM, the 
Amplex Red reagent (10-acetyl-3,7-dihydroxyphenoxazine) in combination with 
horseradish peroxidase (HRP) (Molecular Probes, CA, USA) was used, according 
to manufacturer’s instructions. Phenol-free DMEM was used for this purpose. 
Briefly, 50 µl of DMEM with and without RSV was added to a working solution 
of 100 µM Amplex Red reagent /0.2 U/ml HRP. A positive control of 50 µM 
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H2O2 was used. Absorbance readings were taken at 572 nm using a 
spectrophotometer.  
2.15. Measurement of intracellular O2.- 
Cells were seeded (0.2-0.25 x 106) and grown in 6-well plates (Nuncleon, Nunc, 
Denmark). Intracellular O2.- level was detected using a lucigenin-based 
chemiluminescence assay as described previously (Clement and Stamenkovic 
1996). Cells were washed once with 1x PBS, trypsinized and centrifuged at 2000g 
for 1 minute at room temperature. Cell pellet was resuspended and permeabilized 
in 400 µl of 1x somatic cell ATP releasing agent. 100 µl of 850 µM lucigenin 
solution was automatically injected in the tube containing the permeabilized cells. 
Bioluminescence emitted was measured using a Sirius luminometer (Berthold). 
The luminescence readings generated were normalized to the protein content of 
the corresponding cell lysate. As a positive control, 1mM DDC was used. 
2.16. Measurement of exogenous ROS by the FOX assay 
This was performed using the ferrous ion oxidation-xylenol orange (FOX) method 
(Long et al. 2000). DMEM (90µl) was mixed with methanol (10µl) and incubated 
at room temperature for 30 min. The FOX reagent (900µl) was added, vortexed 
and incubated for 30 min. Solutions were spun at 15,000g for 10 min at room 
temperature and the absorbance at 560 nm was measured against a methanol 
blank. 
2.17. Statistical Analysis 
Statistical analysis was carried out using the Student’s t-test with p<0.05 
considered significant. The statistical software in Microsoft Excel was used. 
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Chapter 3. Results 
3.1 RSV mediates the down-regulation of NHE1 gene expression. 
3.1a RSV represses NHE1 protein expression. 
In the current study, wild-type L6 cells (L6WT) cells were seeded in 10% FBS on 
Day 1, serum starved to 0.5% on Day 2 and supplemented with either 0.5% or 
10% FBS with RSV on Day 3 for the required incubation time. L6WT cells refer 
to those cells which do not the stable integration of the NHE1 proximal promoter 
in its genome. Initial experiments included the effects of a range of RSV 
concentrations at specific time points on NHE1 protein expression. L6WT cells 
were subjected to RSV treatment (0-128 µM) in 0.5% FBS and 10% FBS for 24 
and 48 hours. Low and a high serum conditions were used to determine whether 
the mode of action of RSV on NHE1 protein expression was influenced by serum. 
RSV (128 µM) repressed NHE1 protein expression by 48 hours in both 0.5% and 
10% FBS (Figure 1A and B). The effect of RSV on NHE1 protein down-
regulation was observed in both 0.5% and 10% FBS. This indicates that mitogenic 
factors might not influence the repression of NHE1 protein expression by RSV. It 
was deemed logical to use low serum condition for the rest of the project unless 
otherwise stated. 
To further consolidate the observation that RSV repression of NHE1 expression 
was independent of the nature of the cell line, non-tumorigenic MEF cells and 
epithelial adenocarcinoma MCF7, MDA-MB-231 and T24 underwent treatment 
with RSV in 0.5% FBS. Since the decrease in NHE1 protein expression in L6WT 
occurred after 48 hours and the knowledge that NHE1 protein has a half-life of 
21.4 hours (Cavet et al. 2001), the various cell lines were treated with RSV for 48 
hours before the level of NHE1 protein was assessed. It should be pointed out that 
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due to the relatively different sensitivities of individual cell lines to RSV, the 
concentration ranges were adjusted accordingly. A significant decrease in NHE1 
protein expression was observed at RSV 96 and 128 µM for MEF cells and RSV 
96 µM for MDA-MB-231 cells (Figure 2).  In the case of MCF7 and T24, it was 
32 µM and 4 to 8 µM respectively (Figure 2). The presence of two NHE1 bands in 
T24 and MDA-MB231 cells reflects the presence of both mature (110 kDa) and 
immature (80 kDa) forms of NHE1 (Lacroix et al. 2004). Interestingly, there was 
a differential regulation of the immature NHE1 protein expression. In T24 and 
MDA-MB231 cells, there was an increase in the immature form of NHE1 protein 


















































Figure 1 RSV down-regulates NHE1 protein expression in L6WT. 
L6WT cells were treated with RSV (8-128 µM) in (A) 0.5% and (B) 10% FBS for 
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Figure 2 RSV down-regulates NHE1 protein expression in a cell line-
independent manner. 
(A) MCF7, (B) T24, (C) MDA-MB-231 and (D) MEF cell lines were treated with 
increasing doses of RSV in 0.5% FBS for 48h. NHE1 expression was assessed by 
Western Blot analysis (n=2). In (E) T24 and (F) MDA-MB-231, band intensities 
were quantified and expressed as immature NHE1/ β-actin relative to untreated 






3.1b RSV represses NHE1 promoter activity in a serum-independent manner. 
The effect of RSV on NHE1 promoter activity was investigated. L61.1kb cells 
which are rat skeletal myoblasts stably transfected with 1.1kb of NHE1 proximal 
promoter upstream of the luciferase reporter gene were used. L61.1kb cells were 
treated with RSV (128 µM) over a time period of 4 – 24 hours in 0.5% and 10% 
FBS. RSV (128 µM) significantly repressed NHE1 promoter activity in both 0.5% 
and 10% FBS (Figure 3). The degree of repression of NHE1 promoter activity 
seemed to be independent of serum. In order to verify the integrity of NHE1 
promoter activity, increasing the amount of serum-containing mitogenic factors 
stimulated the NHE1 promoter activity in 10% FBS versus 0.5% FBS (Figure 3) 
as shown previously by Akram et al (Akram et al. 2006). The repression of NHE1 
promoter activity by RSV prompted the investigation of NHE1 protein levels in 
the L61.1kb cells. As observed with the L6WT cells, there was a significant 
repression of NHE1 protein expression by 48 hours (Figure 4A and B). This 
finding consolidated the fact that the integration of the reporter gene in the host 
genome did not disrupt the endogenous NHE1 gene and consequently the effect of 
RSV on NHE1 protein expression. 
3.1c RSV inhibition of NHE1 transcription is independent of the cell line 
used. 
The inherent potential of RSV as a modulator of transcription factors prompted 
further investigation of the action of RSV on NHE1 promoter activity. To 
ascertain that the effect of RSV as seen in L61.1kb cells was really due to its 
effect on NHE1 promoter activity and not an artifact of the stable integration of 
the promoter, plasmid encoding the 1.1kb of NHE1 proximal promoter was 












Figure 3 RSV inhibits NHE1 promoter activity. 
NHE1 promoter activity was assessed by luciferase assay after L61.1kb cells were 















































































Figure 4 RSV down-regulates NHE1 protein expression in L61.1kb. 
L61.1kb cells were treated with RSV (8-128 µM) in (A) 0.5% and (B) 10% FBS 




























the calcium phosphate method before treatment with RSV for 24 hours. NHE1 
promoter activity was significantly inhibited (Figure 5A-E). In order to confirm 
that the inhibition of NHE1 promoter leads to a decrease in NHE1 mRNA 
expression, L61.1kb cells were exposed to 128 µM RSV before NHE1 mRNA 
level was assessed by real-time PCR. Indeed, NHE1 mRNA level decreased 
significantly from 20 h till 72 h (Figure 6A and B). 
3.1d Effect of RSV on cell growth and viability 
In order to rule out that the decrease in NHE1 expression by RSV was due to a 
loss of cell viability, the cytotoxicity of RSV (128 µM) on L61.1kb cells was 
determined. Cellular morphology of L61.1kb cells was observed and a cell 
viability assay was carried out using the crystal violet method. Time 0 hour 
represents the time RSV was added. After 48 hour incubation with RSV, L61.1kb 
cells kept on growing in both 0.5% FBS and 10% FBS, thereby highlighting that 
128 µM of RSV was a non-cytotoxic dose (Figure 7A and B). However, the rate 
of cellular proliferation was impaired (Figure 7B). As a positive control, cells 
treated with 10% FBS showed an enhanced proliferation rate as opposed to their 
counterpart in 0.5% FBS (Figure 7B).  
The above observations suggested that RSV-treated L61.1kb cells were 
undergoing cell arrest. Consequently, L61.1kb cells were stained with propidium 
iodide and their cell cycle profile was analysed. After 48 hour RSV treatment, 
L61.1kb cells accumulated in the G2/M phase (15.34% versus 7.79%) with a 















































































































































Figure 5 RSV inhibition of NHE1 promoter activity is cell-line independent. 
(A) L6WT cells, (B) T24, (C) MCF7, (D) NIH3T3 and (E) M14 cells were 
transiently transfected with XP-1.1MP plasmid containing the 1.1kb NHE1 
proximal promoter upstream of the luciferase reporter gene (pXP-1.1MP) and a 
plasmid encoding for Renilla protein for normalizing transfection efficiency. The 
empty vector pRSVneo (vector) was used as negative control. After transfection, 
cells were treated with RSV (A, D, E =128 µM; B= 8 µM; C= 32 µM) for 24h in 
0.5% FBS. Data were calculated as RLU/renilla/µg total protein and expressed as 






























































































Figure 6 RSV represses NHE1 mRNA level 
(A) RNA was extracted from L61.1kb cells at 20 and 24 hours ensuing treatment 
with RSV (128 µM). cDNA was generated and NHE1 mRNA was quantified 
using Taqman real-time PCR normalized to rat GAPDH. Relative NHE1 mRNA 
level is expressed as fold change of untreated control (n=4). (B) Similar 
experimental setting as in (A) but L61.1kb cells were further treated with RSV at 
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Figure 7 Effect of RSV on L61.1kb cells’ growth and viability. 
(A) Morphology of L61.1kb cells at 0h and 48h post-treatment with RSV (128 
µM) in 0.5% and 10% FBS. Photographs were taken using Nikon digital camera 
DXM1200F via the Nikon ACT-1 Version 2.63 at 40X magnification. (B) 
L61.1kb cells were treated with RSV for 48 h in 0.5% and 10% FBS and cell 
density was measured by crystal violet staining and expressed as OD at 595 nm. 
(n=4) (C) L61.1kb cells were treated with RSV in 0.5% FBS for 48 h and (D) 72 
h. Single cell suspensions of L61.1kb cells were prepared, stained with PI and 


















































There was no apparent increase of cells in sub-G1 phase or G1 phase (Figure 7C). 
These results showed the effect of RSV on NHE1 promoter activity correlates 
with G2/M growth arrest but not drug toxicity. A further increase of cells in the 
G2/M phase was recorded after 72 h treatment with RSV (20.32% versus 7.82%) 
(Figure 7D). In light of these findings, using RSV in 0.5% FBS was deemed a 
rational step in subsequent experiments (unless otherwise stated) and 48 hours 
was the selected time frame to observe any change in NHE1 protein expression. 
Similar non-cytotoxic doses of RSV were determined on MCF7, MDA-MB231 
and T24 cells using the crystal violet technique to assess cell viability (Figure 8). 
3.2 RSV repression of NHE1 gene expression is redox-regulated. 
3.2a RSV triggers production of intracellular ROS. 
RSV is well-known to possess both pro- and anti-oxidant activities. The next step 
was to investigate whether RSV had the ability to generate intracellular ROS. 
L61.1kb cells were incubated with RSV (8-128 µM) and H2O2 (300 µM) for 1 
hour and stained with DCFH-DA, a redox sensitive dye, which is oxidized by 
ROS. Following cells’ exposure to RSV, an increase in DCFH-DA fluorescence 
could be detected (Figure 9A). As a positive control, cells treated with H2O2 
shows an increase in DCFH-DA fluorescence (Figure 9B). In wake of these 
results, using 128 µM RSV, induction of DCFH-DA fluorescence was monitored 
over 4-20 hour time period. RSV induced an increase in intracellular ROS level 
with an increase of 40% at 4 h, 30% at 8 h, 60% at 12 h, 35% at 16h and 50% at 
20 h. Thus, there were two prominent peaks of ROS production at 12 and 20 hour 
(Figure 9C). It has been shown that polyphenolic compounds have the ability to 



















Figure 8 Effect of RSV on tumor cells’ growth and viability. 
(A) MCF7, (B) MDA-MB231 and (C) T24 cells were treated with RSV for 48 h in 
0.5% FBS and cell density was measured by crystal violet staining and expressed 
































































































































Figure 9 RSV triggers intracellular production of ROS 
(A) L61.1kb cells were treated with RSV (8-128 µM) for 1 h and intracellular 
ROS was measured by flow cytometry using the DCFDA dye. Data represents 
average of two independent experiments. (B) L61.1kb cells were treated with 
H2O2 (300 µM) for 1 h and intracellular ROS was measured by flow cytometry 



























































































            
 
Figure 9 RSV triggers intracellular production of ROS 
(C) L61.1kb cells were treated with RSV (128 µM) for 4-20 h and intracellular 
ROS was measured by flow cytometry using the DCFDA dye (n=3). (D) 
Measurement of exogenous ROS production in culture medium using Amplex-red 
kit as described in Materials & Methods. (E) Measurement of exogenous ROS 
production using the ferrous ion oxidation -xylenol orange (FOX) assay. 




















































RSV (128 µM) was incubated in phenol-free medium for 0-2 hours and using the 
amplex-red reagent, the level of ROS was measured.  
Amplex Red reagent reacts with H2O2 in a 1:1 stoichiometry to form a red-
fluorescent oxidation product, resorufin which is measured 
spectrophotometrically. This warranted the use of a phenol-free medium which 
would otherwise interfere in the absorption/emission spectra of the reaction 
products. There was no ROS production upon RSV incubation in DMEM (Figure 
9D). Alternatively, using the FOX assay which involved the use of regular phenol 
Dulbecco’s Modified Eagle Medium (DMEM), there was no ROS production with 
RSV in the medium (Figure 9E). These findings demonstrated that RSV is able to 
trigger an increase in intracellular ROS production.  
3.2b Regulation of RSV-mediated ROS level via ROS scavengers  
The level of intracellular ROS was measured following RSV treatment in the 
presence of dimethylthiourea (DMTU) (10 mM) and catalase (2000 U/ml) over 
specific time periods. DMTU has been shown to be an effective scavenger of 
H2O2 in some biological systems (Curtis et al. 1988). Catalase powder, dissolved 
in the medium, was added to the cells for 24 hours after which RSV in fresh 
medium was added. This allows the catalase proteins sufficient time to diffuse 
into the cells. After 1 and 2-hour treatment, DMTU and catalase lowered 
intracellular ROS significantly. However, there was no obvious change at 4 and 6 
hours. At 12 hours, the ROS scavengers successfully lowered the amount of 


















Figure 10 DMTU and catalase outweigh increase in intracellular ROS. 
L61.1kb cells were treated with DMTU (10mM) in the presence and absence of 
RSV and cells were harvested at the stated times. L61.1kb cells were pretreated 
with catalase (2000U/ml) for 24 hours before fresh medium with and without RSV 
was added and cells were harvested at the stated times. Intracellular ROS was then 
measured by flow cytometry using the DCFDA dye. Data was expressed as fold 
























































3.2c RSV-mediated production of ROS inhibits NHE1 protein expression and 
promoter activity. 
Since NHE1 gene expression is known to be influenced by intracellular and 
exogenous ROS, L61.1kb cells were incubated with DMTU (10mM) with and 
without RSV and NHE1 protein expression was assessed. NHE1 protein 
expression was partially restored upon scavenging of ROS by a significant 10% 
margin (Figure 11). To confirm the role of ROS, L61.1kb cells were over-
expressed with plasmid-encoding catalase by transient transfection followed by 
treatment with and without RSV for 48 hours was performed. Moreover, L61.1kb 
cells were pretreated with 2000 U/ml catalase in the medium for 24 hours before 
subjected to RSV treatment in fresh medium for 48 hours. Over-expression of 
catalase salvaged NHE1 expression by approximately 20% (Figure 12A) while in 
the case of catalase powder, NHE1 protein expression was significantly restored 
(Figure 12B). As a positive control, L61.1kb cells were pretreated with 2000 U/ml 
catalase for 24 hours followed by 50 µM of exogenous H2O2 in fresh medium for 



















    







                   
Figure 11 DMTU rescues repression of NHE1 protein expression by RSV. 
L61.1kb cells were incubated with DMTU (10 mM) with or without RSV (128 
µM) for 48 h in 0.5% FBS. NHE1 protein expression was determined by Western 
blot. Band intensity of NHE1/β-actin ± S.E was averaged as % of RSV-treated 













































                         
 





                                                   









         
Figure 12 Catalase rescues RSV repression of NHE1 protein expression. 
(A) L61.1kb cells were transiently transfected with the plasmid encoding human 
catalase (catalase) and empty vector pCI-neo (vector). Top panel shows the 
overexpression of catalase protein. At 12 h post-transfection, cells were serum 
starved for 24 h and then incubated with RSV (128 µM) for 48 h. NHE1 protein 
expression was analysed by Western blot. Band intensity of NHE1/β-actin ± S.E 











































                 
 
 
     
 
                                                        




                                                  
                                             
 
      
   
 
                           
Figure 12 Catalase rescues RSV repression of NHE1 protein expression. 
(B) L61.1kb cells (lanes 1, 2) were serum deprived for 24 h before being treated 
with RSV (128 µM). L61.1kb cells (lanes 3, 4) were pretreated with catalase 
powder (2000 U/ml) in 0.5% FBS for 24 h before treatment with RSV (128 µM). 
NHE1 protein expression was analysed by Western blot. (C) Similar treatment as 























The same experimental approach was used to investigate the role of scavenging 
ROS on NHE1 promoter activity over a time period of 4-24 hours. The results 
suggested that the initial burst of H2O2 (4-12 hours) did not have a major impact in 
repressing NHE1 promoter since DMTU and catalase did not rescue the promoter 
activity. On the other hand, scavenging the late burst of ROS reinstated NHE1 
promoter activity from 16-24 hours (Figure 13).  
3.2d Oxidation is involved in repression of NHE1 gene expression by RSV 
In order to verify whether oxidation formed part of the signaling pathway 
involved in the repression of NHE1 gene expression by RSV, L61.1kb cells were 
incubated with 500 µM beta-mercaptoethanol (β-ME) in the presence or absence 
of RSV for 48 hours before NHE1 protein expression was probed and over 4-24 
hours before NHE1 promoter activity was measured. β-ME displayed a strong 
rescue of NHE1 protein expression (Figure 14A). The profile obtained from 
NHE1 promoter activity highlighted the involvement of an oxidative process from 
16-24 hours following RSV incubation which was significantly inhibiting the 
promoter activity (Figure 14B). Although RSV was shown to induce an 
intracellular pro-oxidant milieu from 4-20 hours, it appeared that the RSV-
induced ROS affected NHE1 promoter activity in the latter phase and this could 











































Figure 13 Scavenging ROS rescues NHE1 promoter activity but only at a late 
stage. 
L61.1kb cells were treated with DMTU (10 mM) in the presence and absence of 
RSV and cells were harvested at the stated times. L61.1kb cells were pretreated 
with catalase (2000 U/ml) for 24 hours before fresh medium with and without 
RSV was added and cells were harvested at the stated times. NHE1 promoter 
activity was assessed by luciferase assay. (n=4) 
       
                                                                                                                                                                   





















                     











Figure 14 RSV repression of NHE1 gene expression is rescued by reducing 
agent. 
(A) L61.1kb cells were treated with 500 µM β-ME in the presence or absence of 
RSV for 48 hours before NHE1 protein expression was assessed. 
(B) L61.1kb cells were treated with 500 µM β-ME in the presence or absence of 











































3.3 RSV-inhibition of NHE1 gene expression is caspase-dependent. 
3.3a RSV-repression of NHE1 gene expression is inhibited by zVAD. 
Numerous research groups have shown that RSV is involved in orchestrating 
apoptotic cell death via the activation of caspases in either death-receptor 
apoptosis or mitochondria-dependent apoptosis. Additionally, NHE1 expression 
was shown to be influenced by caspase activation whereby caspase-3 cleaving 
NHE1 protein (Wu et al. 2003). On the other hand, NHE1 gene expression was 
regulated by caspase-3 at a transcriptional level (Kumar et al. 2007). To 
investigate whether RSV down-regulation of NHE1 was caspase-dependent, 
L61.1kb myoblasts was incubated with pan-caspase inhibitor, zVAD-fmk (100 
µM) with and without RSV in 0.5% and 10% FBS and NHE1 protein expression 
was assessed by Western blot. The pan-caspase inhibitor was able to rescue NHE1 
protein expression (Figure 15A and B). These results reinforce the initial findings 
that serum did not interfere in RSV-modulation of NHE1 gene expression. Tumor 
cells MCF7, MDA-MB-231 and T24 were incubated with zVAD-fmk (100 µM) 
in 0.5% FBS in the presence of RSV. Similar to L61.1kb cells, decrease in NHE1 
protein expression by RSV was inhibited (Figure 15C, D and E). 
Since the earlier findings implicated that down-regulation of NHE1 protein 
expression by RSV was dependent on the inhibition of transcription, NHE1 
promoter activity was assessed in L61.1kb cells in the presence or absence of 
zVAD. L61.1kb cells were incubated with zVAD-fmk (100 µM) in 0.5% FBS in 
the presence of RSV for a time period of 4-48 hours. At 4 and 8 hours, there was 
an initial partial rescue of NHE1 promoter activity and from 12 hours onwards, 
NHE1 promoter activity was significantly restored (Figure 16A).  
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Figure 15 Down-regulation of NHE1 protein expression by RSV is dependent 
on activation of caspases. 
(A) Pancaspase inhibitor zVAD-fmk (100 µM) was added with or without RSV 
(128 µM) to L61.1kb cells for 48 h in 0.5% FBS. NHE1 protein expression was 
assessed by Western Blot analysis. Band intensity of NHE1/β-actin ± S.E was 
averaged as % of RSV-treated cells over untreated cells (% control) (n=3). (B) 



























































                       
















Figure 15 Down-regulation of NHE1 protein expression by RSV is dependent 
on activation of caspases. 
(C), (D), (E) Pancaspase inhibitor zVAD-fmk (100 µM) was added with or 
without RSV (32 µM, 4 µM and 96 µM respectively) to MCF7, T24 and MDA-
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Figure 16 Inhibition of NHE1 promoter activity by RSV is dependent on 
caspase activation. 
(A) NHE1 promoter activity in L61.1kb cells treated with zVAD-fmk (100 µM) 
with and without RSV (128 µM) over specified time period. Promoter activity was 
assessed by luciferase assay (n=4). (B) RNA was extracted from L61.1kb cells 
after 24 h treatment with zVAD and RSV (128 µM). Relative NHE1 mRNA level 


































































L61.1kb cells were incubated with zVAD-fmk followed by treatment with and 
without RSV for 24 hours and NHE1 mRNA level was measured. The results 
showed that inhibiting caspase activity by zVAD resulted in an increase in NHE1 
mRNA level (Figure 16B). 
3.3b RSV induces caspase-3 and caspase-6 activity in a time-dependent 
manner. 
Having demonstrated that RSV-repression of NHE1 gene expression was caspase-
dependent, the next investigation was to determine the identity of the caspases 
involved in the down-regulation of NHE1 gene expression. A kinetic of caspase-3, 
-6, -8 and -9 activities was carried out following RSV treatment of L61.1kb cells. 
Interestingly, RSV activated caspases-3 and -6 but not caspase-8 and -9 (Figure 
17A). Caspase-3 was activated maximally as early as 4 hours whereas caspase-6 
had a late activation at 20 hours (Figure 17A). To confirm the findings of RSV-
induction of caspase-3 and caspase-6 activities, L61.1kb cell lysates were 
prepared over a time period of 4-24 hours following RSV treatment and a western 
blot experiment was performed to detect cleaved caspase fragments. As expected, 
cleaved caspase-3 heavy fragment (19kDa) was detected from 4-12 hours and 
cleaved caspase-6 fragment (16kDa) was detected at 12-20 hours after RSV 
treatment (Figure 17B and C). To verify whether serum had any effect on RSV-
mediated caspase cleavage, 10% FBS was used in the presence of RSV and 
cleaved caspase-3 and caspase-6 were observed at 4h and 20h after RSV treatment 
thereby showing non-interference of serum (Figure 17D and E). Similar to RSV, 
exogenous H2O2 (100 µM) added to L61.1kb cells induced caspase-3 activity at 4 















Figure 17 RSV activates caspase-3 and caspase-6 in a time-dependent 
manner. 
(A) Total cell extracts from L6 1.1kb cells following RSV (128 µM) treatment at 
varying time intervals were collected and assayed for the activities of caspases-3, 
6, 8, 9. Caspase activity was normalized to protein concentration and expressed as 



























































Figure 17 RSV activates caspase-3 and caspase-6 in a time-dependent 
manner. 
(B) and (C) L61.1kb cells were treated with RSV (128 µM) in 0.5% FBS for 4-20 































































Figure 17 RSV activates caspase-3 and caspase-6 in a time-dependent 
manner. 
(D) and (E) L61.1kb cells were treated with RSV (128 µM) in 10% FBS for 4 and 

















































                                                                           
Figure 18 Exogenous  H2O2 activates caspase-3 and caspase-6.  
Total cell extracts from L61.1kb cells following H2O2 (100 µM) treatment at 4, 8, 
16 and 20 hours were collected and assayed for the activities of caspases-3 (A) 
and -6 (B). Caspase activity was normalized to protein concentration and 
expressed as fold increase of RSV-treated cells over untreated cells (X increase 







































































3.3c Caspase-3 and caspase-6 repress NHE1 gene expression. 
Having established that RSV mediates the activation of caspase-3 and caspase-6, 
the involvement of caspase-3 and -6 in the decrease in NHE1 gene expression by 
RSV was assessed. As such, caspase-3 inhibitor, zDEVD-fmk (100 µM) was 
added with RSV to L61.1kb cells for 48 hour incubation. Similar experimental 
setting was carried out with caspase-6 inhibitor, zVEID-fmk (100 µM). In both 
cases, decrease in NHE1 protein expression was inhibited (Figure 19A and B). 
Meanwhile, the caspase-8 inhibitor zIETD-fmk and caspase-9 inhibitor zLEHD-
fmk (100 µM) did not rescue NHE1 protein expression, showing that neither 
caspase-8 nor caspase-9 are involved in the inhibition of NHE1 gene expression 
(Figure 19C and D). In order to determine the involvement of caspase-3 and -6 in 
NHE1 gene transcription, molecular approaches were used to silence caspase-3 
and caspase-6 RNA. This was followed by incubation of L61.1kb cells with RSV 
for 4-24 hours and its effect on NHE1 promoter activity was evaluated. Silencing 
caspase-3 expression rescued NHE1 promoter activity from 4-12 hours, while 
silencing caspase-6 expression rescued NHE1 promoter activity at 24 hours 
(Figure 20A and B). These results indicate the distinct involvement of caspase-3 
during the early phase of RSV-inhibition of NHE1 gene expression while caspase-

























Figure 19 RSV-mediated caspase-3 and caspase-6 activation is linked to 
NHE1 down-regulation. 
(A) Caspase-3 inhibitor (C3i) (100 µM) was added with or without RSV (128 µM) 
to L61.1kb cells for 48 h in 0.5% FBS. NHE1 expression was assessed by 
Western Blot analysis. Band intensity of NHE1/β-actin ± S.E was averaged as % 
































































Figure 19 RSV-mediated caspase-3 and caspase-6 activation is linked to 
NHE1 down-regulation. 
(B) Caspase-6 inhibitor (C6i) (100 µM) was added with or without RSV (128 µM) 
to L61.1kb cells for 48 h in 0.5% FBS. NHE1 expression was assessed by 
Western Blot analysis. Band intensity of NHE1/β-actin ± S.E was averaged as % 























































Figure 19 RSV-mediated caspase-3 and caspase-6 activation is linked to 
NHE1 down-regulation 
(C) and (D) Caspase-8 inhibitor (C8i) and caspase-9 inhibitor (C9i) (100 µM) was 
added with or without RSV (128 µM) to L61.1kb cells for 48 h in 0.5% FBS. 
NHE1 expression was assessed by Western Blot analysis. Band intensity of 
NHE1/β-actin ± S.E was averaged as % of RSV-treated cells over untreated cells 









































Figure 20 Caspase-3 and caspase-6 repress NHE1 promoter activity. 
(A) L61.1kb cells were transfected with control siRNA (siCo) and specific siRNA 
(100 nM) to caspase-3 (siC-3). 40 h post-transfection, cells were exposed to RSV 
(128 µM) before being harvested at specified time intervals for NHE1 promoter 





























































Figure 20 Caspase-3 and caspase-6 repress NHE1 promoter activity. 
(B) L61.1kb cells were transfected with control siRNA (siCo) and specific siRNA 
to caspase-6 (siC-6). 40 h post-transfection, cells were exposed to RSV (128 µM) 
before being harvested at specified time intervals for NHE1 promoter activity as 









































3.3d Repression of NHE1 promoter activity might involve iron intermediacy. 
The oxidative event that induces apoptosis and subsequent activation of caspases 
has been shown to involve Fenton-type chemistry (Antunes and Cadenas 2001). 
The two major products of a Fenton reaction are the hydroxyl radical (OH.) and 
redox cycling of iron. Therefore, to investigate if OH. was involved in the 
caspase-dependent inhibition of NHE1 protein expression by RSV, L61.1kb cells 
were incubated with sodium formate (HCOONa) - a OH. scavenger, in the 
presence or absence of RSV for 48 hours before assessing NHE1 protein 
expression. HCOONa did not block the repression of NHE1 protein expression by 
RSV (Figure 21A). Analysis of RSV-mediated inhibition of NHE1 promoter 
activity was performed in the presence of either HCOONa or the iron chelator, 
deferoxamine (DFO). L61.1kb cells were incubated with HCOONa for 24 hours 
in the presence or absence of RSV before NHE1 promoter activity was assessed 
while DFO was added with and without RSV and NHE1 promoter activity was 
assessed over 4-24 hour time period. HCOONa did not rescue the repression of 
NHE1 promoter activity by RSV, thus corroborating the results on NHE1 protein 
expression (Figure 21B). On the other hand, DFO salvaged the repression of 
NHE1 promoter activity by RSV from 16 hours onwards (Figure 21C). Taken 
together, these results rule out the involvement of OH. but implicate iron in RSV-







































































Figure 21 RSV repression of NHE1 gene expression is not OH.-dependent but 
may involve iron intermediacy. 
(A) L61.1kb cells were incubated with HCOONa (20 mM) with or without RSV 
(128 µM) for 48 h in 0.5% FBS. NHE1 protein expression was determined by 
Western blot. (n=2). (B) L61.1kb cells were treated with 20 mM HCOONa for 24 
hours with and without RSV (128 µM) before NHE1 promoter activity was 
measured (n=3). (C) L61.1kb cells were treated with 1 mM DFO with or without 











3.3e Intracellular ROS mediates late caspase-6 activation and not the early 
caspase-3 activation. Caspase-3 may induce intracellular ROS production. 
Using the L61.1kb cells, RSV was shown to induce intracellular ROS production 
as well as stimulate the activation of caspase-3 and caspase-6. It was therefore 
logical to verify whether ROS was involved in mediating the activation of 
caspase-3 and caspase-6. L61.1kb cells were incubated in medium-containing 
catalase (2000 units/ml) or DMTU (10 mM) with or without RSV before caspase-
3 and caspase-6 activity were assessed over 4-20 hours. Despite the presence of 
ROS scavengers, caspase-3 was still active at 4-8 hours. DMTU significantly 
decreased the caspase-3 activity from 12-20 hours (Figure 22A). However, it is 
not known why DMTU showed such potency. On the contrary, caspase-6 activity 
was inhibited at 16-20 hours with the ROS scavengers (Figure 22A and B). To 
confirm the finding that caspase-6 activity was ROS-dependent, plasmid-encoding 
catalase cDNA was over-expressed in L61.1kb cells and caspase-6 activity was 
assessed after 20 hours of RSV treatment. Results show that caspase-6 activity 
was significantly inhibited upon overexpression of catalase (Figure 22C). Since 
RSV activated caspases, it was logical to verify whether caspase was involved in 
inducing ROS.  Indeed, using the pancaspase inhibitor zVAD offset the increase 
in ROS production over 1-12 hours after RSV treatment (Figure 23). This finding 
suggests that early caspase activation, in this case caspase-3 might be responsible 
for ROS production. Interestingly, these results highlighted the fact that the initial 
burst of ROS was not involved in caspase-3 activation and was not responsible for 
repression of NHE1 promoter activity. On the other hand, the latter stage of ROS 
production was involved in the inhibition of NHE1 promoter activity together 
















































                   
Figure 22 Caspase-3 activation is ROS-independent while caspase-6 is ROS-
dependent.   
Total cell extracts from L61.1kb cells following RSV (128 µM) treatment over the 
specific times were collected and assayed for the activities of caspase-3 (A) and 
caspase-6 (B) in the presence of DMTU and catalase. Caspase activity was 
normalized to protein concentration and expressed as fold increase of RSV-treated 



















































Figure 22 Caspase-3 activation is ROS-independent while caspase-6 is ROS-
dependent.  
(C) L61.1kb cells were transiently transfected with plasmid-encoding human 
catalase and the empty vector, pCI-neo. 40 hours post-transfection, cells were 
incubated with RSV (128 µM) for 24h before being harvested for caspase-6 
activity respectively. Results are expressed as fold change of RSV-treated cells 
over untreated cells (n=3).   
 










































Figure 23 Inhibiting caspase activity led to a decrease in intracellular ROS 
production 
L61.1kb cells were treated with zVAD at the specific times with and without RSV 
and intracellular ROS was measured by flow cytometry using the DCFDA dye. 











































3.4 Repression of NHE1 gene expression by RSV may be linked to an AP2-
like transcription factor. 
Until now, RSV has been shown to inhibit NHE1 gene expression via repression 
of NHE1 promoter activity. The inhibition of NHE1 promoter activity was 
mediated via the intracellular ROS production by RSV and activation of caspase-3 
and caspase-6. Thus, it was paramount to figure out the region of NHE1 promoter 
that was regulated by RSV. To achieve this aim, L6 cells stably transfected with 
truncated versions of NHE1 promoter which are pXP-1.1MP, pXP-0.9MP, pXP-
0.5MP, pXP-0.2MP, pXP-0.18MP, pMP+AP2 were used (Figure 24A). Each 
construct starts at nucleotides -1100, -808, -515, -171, -155, -125 of the mouse 
NHE1 promoter, respectively (Yang et al, 1996). Each of the L6 cells stably 
transfected with the respective length of NHE1 promoter was treated with RSV 
over a time period from 4-24 hours in 0.5% FBS and NHE1 promoter activity was 
assessed. NHE1 promoter activity was significantly repressed from 4 to 12 hours 
in each construct (Figure 24B). Except for the construct pXP-0.5MP which 
showed that NHE1 promoter activity recovered between 16 and 20 but was again 
significantly repressed at 24 hours (Figure 24B). However, one major observation 
revealed that from 4-12 hours, the margin of repression of NHE1 promoter 
activity was significantly higher than from 16-24 hours (Figure 24B). These 
findings convey the message that RSV repression of NHE1 promoter activity 
entails the presence of at least the smallest fragment of 125 base pairs located 
upstream of the NHE1 transcriptional start site, that is, pMP+AP2, also known as 
the AP-2 like fragment. 
Spurred by these observations, the next step undertaken was to determine whether 
the presence of the AP-2 consensus sequence (-112 bp to -93 bp) was critical in 
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RSV repression of NHE1 gene expression. The AP-2 binding site sequence is 
made up of 9 base pairs, that is, CTTCCCTGGGCGACAGGGGCCG-the AP-2 
consensus sequence being highlighted in bold and italics. Plasmids encoding the 
AP2 fragment (pMP+AP2), devoid of the AP2 fragment (pMP-AP2) and with a 
mutated AP-2 consensus sequence (pMP(Mut)AP-2) were transiently transfected 
in L6WT cells and NHE1 promoter activity was assessed after 24 hour RSV 
treatment. Data showed that the removal of the AP2 binding site resulted in no 
significant change in luciferase activity after RSV treatment (Figure 25A). Using 
the mutated AP2 consensus sequence resulted in insignificant change in NHE1 
promoter activity as well, thereby highlighting the need for an AP-2 like 
transcription factor to elicit NHE1 promoter activity (Figure 25A). As positive 
control, plasmid-encoding AP-1 and NFκB reporter genes were transfected in the 
L6WT followed by addition of RSV before promoter activity was assessed. RSV 
was found to induce activity of NFκB reporter gene whereas the activity of AP-1 
reporter gene was repressed (Figure 25A). To show whether the AP2 like region 
was susceptible to redox-regulation, 50 µM of exogenous H2O2 was added onto 
the stably transfected L6 AP2+ fragment and NHE1 promoter activity was 
assessed after 24 hours. Indeed, the NHE1 promoter activity was significantly 
repressed, highlighting the fact that this region could harbor a transcription factor 
that is redox-regulated (Figure 25B). RSV has been shown to activate caspase-6 in 
HCT116 colon carcinoma cell lines (Lee et al. 2006). Moreover, it has been 
demonstrated that caspase-6 cleaves AP2α in TNFα-induced apoptosis in breast 
cancer cells (Nyormoi et al. 2001). Together with the findings that RSV is acting 
upon an AP2-like transcription factor, the next experiment investigated the 
expression of AP2α in L61.1kb cells, MCF7 and T24 cells following 48 hour of 
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RSV treatment. Indeed AP2α protein expression was significantly down-regulated 
at 128 µM RSV in L61.1kb cells, 16-32 µM in MCF7 and 4-8 µM in T24 cells 
(Figure 26A, B and C). However, those results shown here are only correlative; 
other isoforms of AP2 could be implicated in the regulation of NHE1 gene 





































































Figure 24 RSV repression of NHE1 gene expression is linked to a 33bp region 
upstream of NHE1 transcriptional start site. 
(A) Schematic representation of the 5’ deletion stably-transfected NHE1 promoter 
constructs and the plasmid encoding the AP2 mutated construct. The top box 
shows the AP2 binding region with the AP2 consensus sequence in italic and bold. 
The bottom box represents the mutations made to the AP2 binding site with the 
asterisks highlighting the mutated nucleotides.  
(B) Stable transfectants were treated with RSV (128 µM) for 24 h. Promoter 







































                                                                                                                      
 









Figure 25 RSV repression of NHE1 gene expression is linked to an AP2-like 
transcription factor. 
(A) L6WT cells were transiently transfected with plasmids encoding the AP2+, 
AP2-, AP2 mutant, AP-1, NFκB reporter gene constructs and a plasmid encoding 
for Renilla protein. After transfection, cells were incubated with RSV (128 µM) 
for 24 h. Data were calculated as RLU/renilla/µg total protein and expressed as 
percentage of the promoter activity of RSV-treated cells over untreated cells. 
(n=6) 
(B) Stable transfectant L6AP2+ cells were treated with 50 µM H2O2 for 24 h and 






















































                            
 
 








Figure 26 Down-regulation of AP2α by RSV in non-tumor and tumor cell 
lines. 
(A) L61.1kb, (B) MCF7, (C) T24 cell lines were treated with increasing doses of 
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3.5 Physiological relevance of RSV down-regulation of NHE1. 
3.5a Decreased intracellular pH and rate of pH recovery following acid 
loading. 
Repression of NHE1 gene expression was found to induce intracellular 
acidification concomitant with an increase in cells’ sensitivity to cell death 
triggers (Akram et al. 2006). Having demonstrated that RSV induced down-
regulation of NHE1 protein expression, the next question was to study its 
physiological relevance. As such, it was important to measure the intracellular pH 
since it forms an integral part of the NHE1 functions. This experimental approach 
included the use of L61.1kb myoblasts exposed to RSV in the presence of DMTU, 
catalase and zVAD-fmk for 48 hours after which intracellular pH was assessed. 
RSV-treated samples led to a significant decrease in intracellular pH, by 
approximately 0.2 pH unit (Figure 27A, B, E, F). Intracellular pH was 
significantly restored upon treatment with ROS scavengers DMTU, catalase and 
pan-caspase inhibitor zVAD-fmk (Figure 27A, B, E, F).  
The ability of NHE to extrude H+ ions following an intracellular acid load reflects 
the activity of the exchanger. To this end, RSV-treated samples showed an 
impaired rate of pH recovery following an acid load (Figure 27C and D); using 
DMTU, catalase and zVAD-fmk restored the activity of the exchanger (Figure 
27C and D). Similar findings on intracellular pH and rate of pH recovery were 
obtained when MCF7 cells were incubated with zVAD-fmk (Figure 28A, B, C). 
These results correlated with restoring NHE1 protein expression. It has to be 
noted though that the basal intracellular pH in L61.1kb cells is around 7.1 units 







































































































    
Figure 27 Repression of NHE1 gene expression by RSV-induced H2O2 
production and caspase activation is connected with a drop in intracellular 
pH and impaired pH recovery rate. 
(A) L61.1kb cells were preincubated with and without catalase (2000 units/ml) for 
24 hours before exposure to RSV (128 µM) for 48 hours after which intracellular 
pH was measured. L61.1kb cells were incubated with and without DMTU (10 
mM) in the presence of RSV (128 µM) for 48 hours before intracellular pH was 
measured. (B) L61.1kb cells were treated with RSV (128 µM) in 0.5% FBS with 
and without zVAD (100 µM) for 48 hours before intracellular pH was measured. 
(C) L61.1kb cells were treated with RSV (128 µM) in 0.5% FBS with and without 
catalase (2000 units/ml) and DMTU (10 mM) for 48 hours. Following acid load, 
rate of pH recovery (δpH/δt) was measured as described in Materials and 
Methods. (D) L61.1kb cells were treated with RSV (128 µM) in 0.5% FBS with 
and without zVAD (100 µM) for 48 hours. Following acid load, rate of pH 
















































































































Figure 27 Repression of NHE1 gene expression by RSV-induced H2O2 
production and caspase activation is connected with a drop in intracellular 
pH and impaired pH recovery rate. 
(E) L61.1kb cells were preincubated with and without catalase (2000 units/ml) for 
24 hours before exposure to RSV (128 µM) for 48 hours after which intracellular 
pH was measured. L61.1kb cells were incubated with and without DMTU (10 
mM) in the presence of RSV (128 µM) for 48 hours before intracellular pH was 
measured over time (n=4). 
(F) L61.1kb cells were treated with RSV (128 µM) in 0.5% FBS with and without 



















































Figure 28 Repression of NHE1 gene expression by RSV-induced caspase 
activation in tumor cells is connected with a drop in intracellular pH and 
impaired pH recovery rate. 
(A) MCF7 cells were treated with RSV (128 µM) in 0.5% FBS with and without 
zVAD (100 µM) for 48 hours before intracellular pH was measured as described 
in Materials and Methods (n=4). (B) MCF7 cells were treated with RSV (128 µM) 
in 0.5% FBS with and without zVAD (100µM) for 48 hours. Following acid load, 





























































































Figure 28 Repression of NHE1 gene expression by RSV-induced caspase 
activation in tumor cells is connected with a drop in intracellular pH and 
impaired pH recovery rate. 
(c) MCF7 cells were treated with RSV (128 µM) in 0.5% FBS with and without 













This discrepancy is due to the nature of the cells whereby highly metabolic tumor 
cells have an alkaline intracellular pH with respect to their normal counterparts.  
3.5b RSV induction of G2/M cell arrest in L61.1kb cells is dependent on ROS 
production and caspase activation. NHE1 down-regulation sensitizes L61.1kb 
cells to cell arrest. 
Several reports have demonstrated the role of RSV and its analogs in inducing cell 
arrest in G1/S phase (Bernhard et al. 2000; Joe et al. 2002) and G2/M phase (Lee 
et al. 2004). Besides, NHE1 and intracellular pH have been implicated in 
regulating the timing of G2/M entry and transition (Putney and Barber 2003). 
Subsequently, the role of the inhibition of NHE1 gene expression by RSV on 
L61.1kb cell cycle profile was investigated. First and foremost, since it was shown 
that non-toxic dose of RSV arrested the growth of L61.1kb cells, it was necessary 
to determine whether RSV-induction of caspases was involved in retarding the 
growth of the cells. Thus, a crystal violet assay was carried out to determine cell 
viability of L61.1kb cells after zVAD treatment in the presence or absence of RSV 
for 48 hours. Inhibiting caspase activity increased the cell viability (Figure 29). 
L61.1kb cells were transiently transfected with plasmid-encoding catalase after 
which RSV was added for 48 hours and cell cycle profile was analyzed. The 
results showed RSV increased the percentage of cells in both S and G2/M phases 
(Figure 30A, Appendix 4.9A). However, overexpressing catalase caused G2/M 
stalled cells to clear the G2/M phase together with an increase in DNA replication 
in the S phase (Figure 30B, Appendix 4.9A).   
L61.1kb cells were treated with zVAD for 48 hours with and without RSV. There 
was an increase in the percentage of cells arrest in the G2/M phase while the 
increase in S phase arrest was minimal, corroborating earlier evidence (Figure 
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30C, Appendix 4.9B). Inhibiting caspase activity significantly reduced the 
percentage of cells in the G2/M phase with more cells entering the G1 phase 
(Figure 30D, Appendix 4.9B). Since the response of cells to ROS scavenger and 
caspase inhibition are similar in both treatments in terms of G2/M exit, it is 
therefore possible that the effect seen in over-expressing catalase is a reflection on 
the late activation of caspase-6. In other words, scavenging intracellular ROS 
would decrease caspase-6 activity and consequently, reduced the number of cells 
stalled in the G2/M phase. Alternatively, based on the fact that caspase-3 might 
induce ROS production, inhibiting caspase-3 via zVAD treatment might repress 
ROS production and thus reduced the number of cells in the G2/M phase.  
The results suggested that restoring NHE1 expression by catalase or zVAD could 
explain the effect observed in G2/M cell cycle progression. In order to find out the 
role of NHE1 in cell cycle, NHE1 gene was silenced (Figure 31A) in L61.1kb 
cells and cell cycle profile was analyzed after RSV treatment for 48 hours. 
Interestingly, silencing NHE1 gene expression alone did not alter the percentage 
of cells in the G2/M phase; however, addition of RSV enhanced the percentage of 
cells in the G2/M phase, suggesting that NHE1 down-regulation might further 
sensitize L61.1kb cells to arrest in the G2/M phase (Figure 31B, 31C, Appendix 
4.9C). Alternatively, RSV might be targeting a different protein other than NHE1, 


















Figure 29 Treatment of L61.1kb cells with zVAD enhanced cell viability. 
L61.1kb cells were treated with RSV for 48 h in 0.5% FBS and cell density was 























































































































































Figure 30 RSV-induced H2O2 production and caspase activation is connected 
with an increase in G2/M cell arrest. 
(A) L61.1kb cells were transiently transfected with the plasmid encoding human 
catalase and empty vector, pCI-neo. At 12 h post-transfection, cells were serum 
starved for 24 h and then incubated with RSV (128 µM) for 48 h. Single cell 
suspensions of L61.1kb cells were then prepared, stained with PI and analyzed by 
flow cytometry (n=4). (B) Percentage of cells in the G2/M phase after catalase 
transfection. (C) Pancaspase inhibitor zVAD-fmk (100 µM) was added with or 
without RSV (128 µM) to L61.1kb cells for 48 h in 0.5% FBS. Single cell 
suspensions of L61.1kb cells were then prepared, stained with PI and analyzed by 















































































Figure 31 Repression of NHE1 gene expression by RSV sensitized cells to 
G2/M cell arrest. 
(A) L61.1kb cells were transiently transfected with control siRNA (cosiRNA) and 
specific siRNA to NHE1 (NHE1siRNA). Western blot showing the degree of 
silencing. (B) 40 h post-transfection, cells were exposed to RSV (128 µM) for 48 
hours. Single cell suspensions of L61.1kb cells were then prepared, stained with 
































3.6 Low dose of RSV increases NHE1 gene expression. 
Since low dose of RSV induced an increase in intracellular O2.- and O2.- was 
shown to mediate an increase in NHE1 gene expression (Akram et al. 2006), the 
effect of RSV on NHE1 protein expression and promoter activity was probed.  
3.6a RSV triggers intracellular O2.- production. 
Reports by Ahmad et al showed that low doses of RSV (4-8 µM) conferred 
survival ability to HL-60 cells when challenged by an apoptotic trigger (Ahmad et 
al. 2004a). This survival advantage was due to the pro-oxidant state generated by 
low dose of RSV. In fact, low dose of RSV was shown to generate an increase in 
intracellular O2.- level. As a matter of fact, 8-16 µM RSV was added onto L61.1kb 
cells in 0.5% FBS and the level of intracellular O2.- was assessed by the lucigenin 
method. L61.1kb cells were maintained in 0.5% FBS for increasing serum level is 
known to increase O2.- level (Akram et al. 2006) and this could eventually mask 
the increase in O2.- level. Indeed, 8-16 µM RSV triggered an increase in detectable 
level of intracellular O2.- for 1-2 hours after treatment (Figure 32A). As a positive 
control, treatment of L61.1kb cells with DDC showed a considerable increase in 
O2.-  level (Figure 32B). 
3.6b Low doses of RSV increase NHE1 protein expression and stimulated 
NHE1 promoter activity. 
Low dose of RSV (8-16 µM) stimulated NHE1 promoter activity at early time 
points (4-12 hours) while moderate doses of RSV (32-64 µM) maintained the 
increase in NHE1 promoter activity for a longer period till 24 hours (Figure 33 A-
D). This effect of RSV (8-64 µM) on activating NHE1 promoter was seen in 10% 
FBS as well (Figure 34A). Interestingly, the range of RSV dose (8-64 µM) 
stimulated the activity of the various NHE1 promoter constructs. These results 
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indicate that the AP2+ fragment is sufficient enough to drive activation of NHE1 
promoter activity after exposure to low doses of RSV. 
To verify RSV-induction of NHE1 promoter activity, NIH3T31A8, stably 
transfected with NHE1 promoter was treated with 8 µM RSV for 4 hours in 0.5% 
and 10% FBS. As expected, NHE1 promoter activity was significantly increased 
(Figure 34B ad C). 
L61.1kb cells were subjected to 8-64 µM RSV in both 0.5% and 10% FBS for 48 
hours before NHE1 protein expression was assessed by Western blot analysis. 
NHE1 protein expression increased in 0.5% FBS after 48 hours; however, that 
increase in NHE1 protein expression was not prominent in 10% FBS (Figure 35A 
and B).  
A cell viability assay using the crystal violet technique was performed on L61.1kb 
cells with RSV (8-128µM) for 48 h. The range of dose of RSV that increased 
NHE1 gene expression, that is 8-64µM, did not result in a significant change in 












































Figure 32 Low dose of RSV and DDC triggered an increase in O2.- level. 
(A) L61.1kb cells were treated with 8 µM (RSV 8) and 16 µM (RSV 16) of RSV 
in 0.5% FBS for 1 and 2 hours. Level of O2.- was measured using the lucigenin 
assay (n=2). (B) L61.1kb cells were treated with DDC (1 mM) for 2 hours and the 








































































































































































Figure 33 Stimulation of NHE1 promoter activity by RSV in 0.5% FBS. 
(A) - (D) Stable transfectants were treated with 8,16,32,64 µM of RSV 






































































































Figure 34 Stimulation of NHE1 promoter activity by RSV in 10% FBS. 
(A) L61.1kb cells were treated with RSV (8-64 µM) for 4-24 h in 10% FBS. 
Promoter activity was assessed by luciferase assay. (n=4) 
(B) and (C) NIH3T31A8 cells were treated with 8 µM of RSV (RSV 8) for 8 











































































































Figure 35 RSV up-regulates NHE1 protein expression. 
L61.1kb cells were treated with RSV (8-64 µM) in (A) 0.5% and (B) 10% FBS for 
48 h before NHE1 protein expression was assessed by Western Blot analysis. In 
(A) and (B), band intensities were quantified and expressed as NHE1/β-actin 
relative to untreated sample (% control) and are shown as mean of 3 separate 



































































0 8 16 32 64RSV/µM
NHE1
β-actin












Figure 36 Effect of RSV (8-128µM) on L61.1kb cells’ viability. 
L61.1kb cells were treated with RSV for 48 h in 0.5% FBS and cell density was 




































Chapter 4. Discussion 
4.1 RSV represses NHE1 gene expression. 
4.1a RSV inhibits NHE1 protein expression by 48 hours. 
Dose-response over a time period of 24-48 hours was initially performed on 
L61.1kb using RSV to monitor the change in NHE1 protein expression. At high 
dose of RSV (128µM), NHE1 protein expression decreased significantly after 48 
hours treatment. Since L61.1kb cells are stably-transfected with 1.1kb proximal 
fragment of NHE1 promoter, it was deemed essential to carry out the same 
experiments on L6WT cells to rule out any interference of the stably-transfected 
fragment with endogenous NHE1 promoter. The same pattern of results was 
obtained in L6WT cells. This observation is in accord with the fact that the 
110kDa NHE1 protein has a half-life of 23.1 ± 2.3 hours and consequently, any 
change in protein expression would become obvious after 24 hours (Cavet et al. 
2001). It is known that following the incubation of human renal proximal tubule 
cells in a hypertonic and serum-free medium, NHE1 protein can be cleaved by 
caspase-3 after 6 hours (Wu et al. 2003). So, in the case of L61.1kb cells, the 
down-regulation of NHE1 protein expression by RSV might not be related to 
cleavage of the protein. Furthermore, the repression of NHE1 protein expression 
by RSV occurs in 0.5% and 10% FBS. This indicates that the inhibition of NHE1 
gene expression was independent of mitogenic factors in serum. 
4.1b Rationale using serum-deprived conditions and its impact on the study. 
Most of the experiments in this study were conducted in 0.5% FBS in order to 
minimize the interference of any other potential mitogenic factor(s). It could well 
be argued that serum deprivation puts the cells under stress but as shown from the 





10% FBS, albeit at a slower rate and the cells were not undergoing apoptosis in 
0.5% FBS.  
RSV (25µM) was found to induce apoptosis in serum-stimulated vascular smooth 
muscle cells while the same dose could not induce apoptosis in the same quiescent 
cells (Mnjoyan and Fujise 2003). Thus, the effect of RSV might vary on the type 
of cell line. Besides, it is known that skeletal muscle cells have calcineurin B 
homologous proteins 1 and 2 (CHP1 and CHP2). CHP2 has the ability to activate 
NHE1 activity in serum-deprived tumor cells over a span of 7 days which would 
otherwise undergo cell death (Pang et al. 2001). It is likely that L61.1kb cells and 
the tumor cells used are able to overcome the serum-deprivation stress by one 
such mechanism. The condition of using 0.5% FBS was deemed satisfactory to 
investigate the mechanism of RSV down-regulation of NHE1 expression. 
4.1c RSV down-regulates NHE1 promoter activity independent of serum. 
Since the decrease in NHE1 protein expression was not due to its cleavage, it was 
logical to assess whether that change was due to a repression of NHE1 
transcriptional mechanism. Mitogenic factors such as EGF, thrombin and insulin 
are known to stimulate NHE1 promoter activity (Besson et al. 1998). Thus, the 
effect of RSV on NHE1 promoter activity was probed. NHE1 promoter activity 
was significantly inhibited by 30% relative to control over a 24-hour period. 
Similarly, a significant decrease of NHE1 mRNA was recorded by 24 hours. 
Clearly, RSV was targeting NHE1 transcriptional activity. Transient transfection 
of plasmid-encoding the 1.1kb fragment of NHE1 promoter in mouse fibroblasts 
NIH3T3 and tumor cells M14 bolstered the findings that RSV was indeed 
antagonizing NHE1 promoter activity and the effect was cell line independent. 
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On the other hand, repression of NHE1 promoter activity by RSV was 
independent of serum. Increasing serum concentration was shown to increase 
NHE1 mRNA and cellular proliferation (Rao et al. 1990; Besson et al. 1998). It 
was therefore logical to investigate the role of RSV on NHE1 gene expression in 
both quiescent and proliferating cells. Cells were rendered quiescent by serum 
deprivation, that is, 0.5% FBS and made to proliferate, that is 10% FBS (Briehl 
and Miesfeld 1991; Dobrazanski et al. 1991). Higher serum concentration was an 
agonist for NHE1 promoter activity with respect to low serum conditions, 
corroborating the findings of Besson et al (Besson et al. 1998). This was reflected 
in an increase in NHE1 protein levels as well by 48 hours. The presence of serum 
did not affect the mode of action of RSV. This is reminiscent of COUP-TFI and 
COUP-TFII (Fernandez-Rachubinski and Fliegel 2001) and thyroid hormone 
receptor (Li et al. 2002b) being able to upregulate NHE1 promoter activity in both 
0.5% and 10% FBS, although the upregulation was higher in 10% FBS. 
4.2 Intracellular generation of ROS by RSV: A new perspective to RSV 
mechanism of action. 
4.2a Anti-oxidant ability of RSV 
Under normal cellular metabolism, ROS such as O2.-, H2O2 and OH. are generated 
to a certain level that is kept under control by anti-oxidant defense enzymes 
consisting of glutathione, superoxide dismutase and catalase (Halliwell and 
Gutteridge, 1999). As explained in the introduction, dysregulated production of 
ROS oxidised low-density lipoproteins (LDL) which is responsible for the 
development of atherosclerosis (Esterbauer et al. 1992). RSV has been shown to 
be a potent inhibitor of LDL oxidation. Others have shown that this anti-oxidant 
ability of RSV stems through its inhibition of copper-catalysed oxidation of LDL 
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(Frankel et al. 1993). Cancer researchers showed that RSV counteracted the 
elevation in intracellular ROS induced by tumor promoter phorbol ester, thus 
dampening the likelihood of a pro-oxidant milieu necessary for carcinogenesis 
(Martinez and Moreno 2000). The other isomer of RSV, cis-RSV has been shown 
to inhibit O2.- , NO. and prostaglandin production in murine macrophage, thereby 
inhibiting inflammatory responses which are the seeding ground for tumorigenesis 
(Leiro et al. 2004). However, in a number of reports, the effect of RSV as an anti-
oxidant was measured using the chemiluminescence method which employs 
lucigenin or luminal in the presence of HRP. RSV (trans-isomer) is thought to act 
as a reducing substrate for HRP and thus compete with the redox probes (Poolman 
et al. 2005). Therefore, RSV acting as an anti-oxidant should be carefully 
interpreted. 
4.2b Pro-oxidant feature of RSV: an emerging finding of substantial 
implication 
The amount of exogenous or endogenous ROS determines the cells fate. As such, 
ROS acting as second messengers are known to activate MAPK, PKC, PLC and 
transcription factors like AP-1 and NFκB (Kamata and Hirata 1999). An excessive 
unbridled level of ROS is known to drive cellular pathogenesis. The data 
presented in this thesis showed that RSV harnesses the ability to generate 
intracellular ROS as measured by the fluorescent redox probe, DCFDA. This 
finding prompted the verification whether ROS was being synthesized upon 
reaction of RSV and the cell culture medium used, in this case, Dulbecco’s 
Modified Eagle Medium (DMEM). RSV did not react with DMEM to produce 
ROS, thus ruling itself out of the phenolic compounds such as epigallocatechin 
and quercetin which were shown to generate H2O2 in DMEM in a cell-free system 
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(Long et al. 2000). Recently, a few reports have shed light on the pro-oxidant 
potential of RSV. Using androgen-insensitive prostate cancer cells, PC3, RSV was 
shown to enhance TRAIL-induced apoptosis (Shankar et al. 2007). RSV generated 
intracellular H2O2 which peaked after 2 hours of incubation. Treatment of the cells 
with N-acetylcysteine inhibited RSV-driven ROS production and RSV activation 
of caspase-3, thereby reducing apoptosis of the cancer cells (Shankar et al. 2007). 
In HT29 human colon cancer, RSV elicited intracellular H2O2, upstream of 
AMPK activation and subsequently apoptosis (Hwang et al. 2007). Besides its 
ability to generate H2O2, low doses of RSV is known to trigger O2.- production in 
HL60 human leukemic cells thereby inhibiting drug-induced apoptosis (Ahmad et 
al. 2003; Ahmad et al. 2004a). 
4.2c RSV has the ability to induce NO. production 
However, the ability of RSV to induce reactive nitrogen species in particular NO. 
has been reported in several studies. NO. was found to confer protection to the 
heart when grape juices and grape skins were shown to relax precontracted 
smooth muscle of intact rat aortic rings and not aortas devoid of its endothelium 
(Fitzpatrick et al. 1993). Extracts from grape juices increased cGMP levels in 
vascular tissue and both relaxation and cGMP increase were counteracted by NG-
monomethyl-L-arginine and NG-nitro-L-arginine which are competitive inhibitors 
of NO.. These observations highlighted the relationship between vasorelaxation 
and the NO-cGMP pathway. A more direct evidence of RSV-induction of NO. 
derives from a study whereby RSV increased NOS activity in cultured pulmonary 
artery endothelial cells (Hsieh et al. 1999). Since RSV has the ability to induce 
ROS production in cardiac muscle cells, it is sensible to assume that a similar 
process might happen in the L6 skeletal muscle cells. The use of astringinin, a 
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RSV analog, provided beneficial effects on ischemia and reperfusion damage in 
rat heart in an NO-dependent manner (Hung et al. 2001). Pretreatment with 
astringinin significantly reduced ventricular tachycardia and ventricular 
fibrillation during either ischemia or ischemia-reperfusion period and thus 
decreased mortality of the animals. During the same time period, NO. level was 
elevated and LDH level was reduced in the carotid blood. Consistent with these 
results, cardioprotection by RSV was attributed to upregulation of iNOS – an 
effect abrogated by iNOS inhibitor, aminoguanidine. Besides, iNOS knockout 
mice devoid of any copy of iNOS gene were no longer protected by RSV 
(Imamura et al. 2002). A recent study revealed that RSV reduced myocardial 
ischemia-reperfusion injury in both an iNOS-dependent and iNOS-independent 
manner (Hung et al. 2004). It is thus possible that in the L6 skeletal muscle cells, 
RSV induction of ROS could be partly due to an increase in iNOS expression and 
subsequently NO. production that eventually led to increased cell growth arrest 
(Agusti et al. 2004). 
4.2d Pro-oxidant versus Anti-oxidant nature of RSV: Structure-Function 
being the cause 
RSV and its analogs were used to investigate their anti-oxidant potential in 
inhibiting linoleic acid peroxidation (Cai et al. 2004). Linoleic acid was mixed 
with acetyl-trimethylammonium bromide micelles to mimic the microenvironment 
of plasma membranes (Fang et al. 2002). Peroxidation of linoleic acid was 
achieved via the addition of water-soluble azobis (methylpropionamidine) 
dihydrochloride and generated 11-hydroperoxide, which rapidly isomerized to 
conjugated 9- and 13-hydroperoxides. The inhibition of hydroperoxides 
production was a measure of the anti-oxidant capability of RSV and its analogs.  
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RSV with its 3,5,4’-trihydroxyl groups showed fair amount of anti-oxidant ability 
(Cai et al. 2004). RSV analogs with 3,4,4’-trihydroxyl (A) and 3,4-dihydroxyl (B) 
groups demonstrated higher anti-oxidant ability (Cai et al. 2004). It seems that by 
exchanging the positions of hydroxyl groups along the benzene rings enhances its 
anti-oxidant ability. The anticancer property of RSV and other polyphenols was 
recently highlighted in their ability to mobilize endogenous copper in human 
peripheral lymphocytes, leading to oxidative DNA damage (Azmi et al. 2006). 
Zheng et al reported that RSV is able to convert Cu(II) to Cu(I) via an 
intermolecular electron transfer process leading to the oxidation of the 4-hydroxyl 
group on RSV. In the process, O2.- is generated. Unlike RSV, the other analogs are 
able to chelate Cu(II) and via intramolecular electron transfer generating Cu(I), 
O2.- is generated as well (Zheng et al. 2006). Obviously, generation of O2.- can be 
readily converted to H2O2 in cellular systems, thereby consolidating the fact that 
RSV can induce an intracellular pro-oxidant state. 
4.3 RSV-mediated activation of caspases is not linked to cell death. 
4.3a RSV signaling via activation of caspase-3 and caspase-6  
The data provide evidence that RSV activates both caspase-3 and caspase-6 in a 
time-dependent manner, with caspase-3 at an early time point (4-8 hours) and 
caspase-6 at a late phase (16-20 hours). This observation is interesting since both 
caspase-3 and caspase-6 are two known executioner caspases and their disparate 
temporal stimulation pointed towards a possibility of caspase-3 activating 
caspase-6. Report by Srinivasula et al, showed that caspase-3 cleaves caspase-6 
resulting in its activation (Srinivasula et al. 1996). Furthermore, incubation of pro-
caspase-6 with granzyme B (a cytoplasmic granule serine protease which mediates 
apoptotic events) in the presence of cellular extracts containing pro-caspase-3 
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resulted to the activation of caspase-3 and subsequently caspase-6 (Srinivasula et 
al. 1996). At the same time of Srinivasula’s publication, another report by Liu et 
al demonstrated that caspase-6 has the ability to activate caspase-3 (Liu et al. 
1996). Caspase-6 was identified and purified from hamster liver extract and was 
found to activate caspase-3 leading to apoptotic cell death (Liu et al. 1996). RSV 
has been shown to induce S phase arrest and caspase-6 activation leading to 
apoptosis in CEM-C7H2 acute leukemic cells (Joe et al. 2002). Thus it is likely 
that the activity of caspase-3 and caspase-6 in this particular system are totally 
unlinked. Besides, data from the NHE1 promoter activity where caspase-3 
expression was silenced indicated that caspase-3 might not be directly involved in 
the activation of caspase-6. This is because after silencing caspase-3, NHE1 
promoter activity was not rescued at 20-24 hours post-treatment with RSV. It was 
interesting to note that neither caspase-8 nor caspase-9 (both initiator caspases) 
was active in the L61.1kb cells. Thus, it appears that the traditional extrinsic 
(death-receptor) and intrinsic (mitochondrial-driven) do not take place in the 
system employed. The activation of caspase-6 was ROS-mediated, a phenomenon 
that has been previously described. On the ther hand, activation was caspase-3 is 
quite puzzling since it was not ROS-independent and was activated at an early 
time point. One plausible hypothesis is that RSV might interact with caspase-3 
and elicit its activation. Alternatively, the activity of caspase-3 could be 
determined prior to 4 hours and whether its activation is ROS-mediated could be 
answered. 
Although activation of caspases has been associated with apoptotic cell death, 
RSV-induced caspase activation did not result in cell death of L61.1kb cells. 
Instead, the cells underwent cell arrest mainly in the G2/M phase and inhibiting 
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caspase activation using zVAD-fmk released the population of G2/M arrested 
cells. These findings are reminiscent of the diverse functions of caspase activation 
particularly the role of caspases in cell cycle progression. For instance, caspase-3 
knock-out mice showed hyperproliferation of B cells, indicating caspase-3 acts as 
a negative regulator of B-cell cycling (Woo et al. 2003). Caspase-3 cleavage of 
the CDK inhibitor p21 at the C terminal PCNA-binding site prevents the 
interaction of p21 with PCNA, thereby inhibiting proliferation in B cells (Frost et 
al. 2001). On the other hand, nuclei of dividing cells in the rat forebrain display 
active caspase-3 and in proliferating lymphoid cells, cleavage of CDK inhibitor 
p27KIP1 by caspase leads to induction of cell cycle progression (Yan et al. 2001b). 
Furthermore, the transcription factor NFAT is a substrate for caspase-3 in cycling 
T cells which consequently have lower NFAT protein expression and NFAT 
transcriptional activity (Wu et al. 2006). 
4.3b Role of caspases, other than cell death. 
Activation of caspases has been classically linked to programmed cell death.  
Ligands belonging to the TNF family bind to their respective death receptors and 
trigger apoptosis via the caspase network. HeLa cells are rescued from apoptosis 
by TNF and cycloheximide (CHX) through zVAD-fmk (Luschen et al. 2000). 
Interestingly, NIH3T3 cells displayed a significant degree of hypodiploid cell 
upon addition of TNF and zVAD-fmk. Besides, there was an accumulation of 
cells in the G2/M phase which was thought to sensitize NIH3T3 cells to cell death 
(Luschen et al. 2000). A few studies performed at the same time revealed a 
necrotic-like form of cell death upon caspase inhibition on TNF cytotoxicity in 
L929, NIH3T3 and U937 cell lines. However, Luschen et al reported the 
observation of DNA fragmentation that was indistinguishable between 
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TNF/zVAD-fmk and TNF/CHX treatment in NIH3T3 cell line (Luschen et al. 
2000). Furthermore, zVAD-fmk was reported to enhance the generation of ROS 
by TNF in L929 cells, with butylated hydroxyanisole (BHA) and N-acetylcysteine 
(NAC) able to offset the effect (Cauwels et al. 2003). Again, these findings were 
in disagreement from Luschen et al who questioned the validity of TNF/zVAD-
fmk ability to induce ROS production.  
4.4 RSV-regulation of NHE1 gene expression might occur via an AP2-like 
transcription factor. 
It is well documented that RSV modulates cell physiology by influencing the 
actions of transcription factors such as NFκB, AP-1, estrogen receptor (ER) and 
aryl hydrocarbon receptors (AHR). It was of paramount importance to figure out 
which transcription factor was involved in RSV-regulation of NHE1 gene 
expression. Our results showed that a region of 125 base pairs upstream of the 
transcriptional start site was required for RSV-modulation of NHE1 promoter 
activity. This region encompasses an AP2 DNA binding consensus sequence. 
Using DNA sequence without and mutant AP2 consensus region revealed that 
RSV is indeed targeting an AP2 like transcription factor. Indeed, using a 
dominant-negative isoform of AP2, NHE1 protein expression plummeted (Kumar 
AP et al, unpublished data). 
NHE1 promoter activity has been investigated by a number of researchers. 
Mitogens such as serum, epidermal growth factor (EGF), genistein, phorbol-
myristate acetate (PMA) and insulin were all shown to activate the 1.1kb of NHE1 
promoter activity (Besson et al. 1998). The authors went on further to show that 
these mitogens were targeting a region between -1085 and -808 of the NHE1 
promoter (Besson et al. 1998). However, their data with serum is in disagreement 
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with our findings which showed that serum is able to activate the AP2+ fragment 
of the NHE1 promoter. This discrepancy could be due to the fact that in their 
studies, Besson et al measured the NHE1 promoter activity at a single time point, 
which is 24 hours, after addition of serum. Since transcription is a dynamic 
process, it is essential to follow the progress of the promoter activity over a certain 
time period. Dyck et al showed that mutation of base pairs between -106 and -95 
of the NHE1 promoter significantly reduced in vivo transcription and binding of 
nuclear extracts to this region; an effect attributed to an AP2 like transcription 
factor. Transfection of AP2 expression plasmid in HepG2 cells increased NHE1 
transcription levels. Activation of the promoter of acetyl-CoA carboxylase gene 
was found to be mediated by AP2 transcription factor (Park and Kim 1991). 
Cellular differentiation which is known to increase NHE1 mRNA does enhance 
AP2 transcription too. For instance, retinoic acid differentiation of human 
leukemic cells and NT2 teratocarcinoma cells showed increased NHE1 and AP2 
mRNA and protein levels respectively (Williams et al. 1988; Rao et al. 1992). 
Moreover, RSV is known to increase nuclear expression of AP2α and AP2γ in 
human breast cancer cell line, MCF-7 thereby regulating human erbB2 gene 
expression (Choi et al. 2006). These observations point to the potential role of 
RSV on an AP2 –like transcription factor in regulating NHE1 gene expression. 
4.4a RSV-induction of ROS and caspases might influence the function of 
AP-2. 
Effects of DNA methylation on superoxide dismutase 2 (SOD2) promoter activity 
revealed an AP2 cis-element whose methylation status decreased AP2 DNA 
binding and SOD2 promoter activity (Huang et al. 1997). Huang and Domann 
went on further to demonstrate that both diamide, a chemical oxidant and H2O2 
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were capable of inhibiting AP2 DNA binding activity as well as inducing covalent 
modifications of the protein in vitro. Using dithiothreitol and β-mercaptoethanol 
which are disulfide bond reducing agents, AP2 conformation and DNA binding 
activity were reinstated (Huang and Domann 1998). AP2 protein contains seven 
cysteine (Cys) residues of which six are involved in DNA binding and 
dimerization domains. Cys 222 and Cys 243 are located specifically in the DNA 
binding domain (Bosher et al. 1996; Buettner et al. 1993) and are believed to be 
redox-regulated. This hypothesis is based upon the fact that cysteine residues in 
DNA binding domains of other transcription factors such as AP-1 and NFκB are 
well conserved and redox-regulated too. For instance, redox-regulation of one 
single conserved cysteine residue in the binding domains of Fos-Jun heterodimer 
modulated their DNA binding (Abate et al. 1990). Reduction of the disulfide bond 
in Cys 62 of NFκB (p50 subunit) by thioredoxin was involved in NFκB DNA 
binding and dimerization activities (Matthews et al. 1992). Moreover, the 
induction of ICAM-1 gene by singlet oxygen was linked to the redox-sensitive 
transcriptional activity of AP2 in cultured human skin cells (Grether-Beck et al. 
1996). 
Transcription factor AP2α is known to display both cell survival and cell death 
properties. TNFα down-regulates AP2α in breast cancer cells accompanied by 
TNFα-induced apoptosis (Nyormoi et al. 2001). This AP2α down-regulation was 
not due to reduction in gene transcription but the transcription factor was cleaved 
by caspases. TNFα activated caspases-1, 2, 3, 6, 8, 9 but caspase-6 was the main 
caspase involved in cleaving AP2α (and caspase-3 to a lesser extent) (Nyormoi et 
al. 2001). Using recombinant caspase-6 and in vivo-activated caspase-6 like 
enzymes, both were able to mediate degradation of AP2α in vitro. Cleavage of 
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AP2α inhibited its DNA binding activity and played a central role in TNFα -
mediated apoptosis of breast cancer cells (Nyormoi et al. 2001). Besides, RSV has 
been demonstrated to elicit caspase-6 activation, triggering lamin A cleavage and 
apoptosis in HCT116 colon cancer cell lines (Lee et al. 2006). Therefore, it is a 
plausible scenario that in L61.1kb cells, caspase-6 might be involved in cleaving 
AP2 and thus inhibiting its binding activity leading to decrease of NHE1 gene 
expression.  
4.4b Regulation of NHE1 gene expression by RSV might involve other 
transcription factors. 
The distal enhancer element (-841/-800) of NHE1 promoter which harbors the 
chicken ovalbumin upstream promoter-transcription factors (COUP-TF) 
constitutes a binding region for thyroid hormone receptor (TR) as well (Li et al. 
2002b). Thyroid hormone is known to increase NHE activity in proximal straight 
tubules of neonatal rabbits and enhances NHE3 transcription (Shah et al. 2000). 
3,5’,3’-triiodothyronine (the most active form of thyroid hormone) directly 
stimulates NHE activity in L6 cells (Incerpi et al. 1999). Despite sharing the same 
binding element as COUP-TF, TR binds onto a region that is near to COUP-TF 
(Li et al. 2002b). It has been propounded that COUP-TF and TR can cooperate to 
act synergistically to a certain degree since transfection of plasmids-containing 
each of the protein together resulted in a greater NHE1 promoter activity than 
when transfected alone (Li et al. 2002b). Besides, thyroid hormone causes MAPK-
dependent phosphorylation of nuclear ER in MCF7 cells (Tang et al. 2004). It is 
possible that TR and COUP-TF might cooperate with AP2 to induce NHE1 gene 
expression and that RSV might repress NHE1 gene expression by inhibiting this 
cooperativity. 
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An insight in the homology of the proximal region of human and mouse NHE1 
promoter revealed a highly conserved poly (dA:dT) region located at -170/-155 
upstream of the transcriptional site (Yang et al. 1996b). The region appeared to be 
important in NHE1 gene expression since its deletion or mutation results in 
significant decrease in NHE1 promoter activity in both L6 and NIH3T3 cells 
(Yang et al. 1996b). Besides, the protein that bind the poly (dA:dT) belonged to 
the high-mobility group (HMG) family of proteins which is known to bind to AT-
rich regulatory elements of promoters (Wang et al. 1997). On the other hand, 
Kolyada et al demonstrated that the proximal region of human NHE1 promoter (-
239/-215bp) is essential in regulating human NHE1 gene expression in HepG2 
and vascular smooth muscle cells (VSMC). Transcription factors such as CREB, 
AP3, NFY and CCAAT box-binding proteins (C/EBPα) have been mapped to that 
particular region (Kolyada et al. 1994). Studies by Das et al showed that RSV 
(10µM) phosphorylated and activated CREB in cardiomyocytes and this conferred 
cardioprotection (Das et al. 2005). Since down-regulation of NHE1 expression has 
been linked to increased sensitivity to cell death (Akram et al. 2006), RSV 
repression of NHE1 gene expression might involve inactivation of CREB.  
4.4c Possible mechanisms of RSV interaction with transcription factors 
Amidst the various functions of RSV lies its ability to regulate the expression 
and/or activity of transcription factors. Several reports have shown the effect of 
RSV on the function of NFκB and AP-1 – two very common transcription factors. 
Emerging evidence shows that RSV can bind directly to transcription factors 
thereby influencing their activity. RSV is known to bind to the ER family namely 
ERα and ERβ. The binding of RSV to ER was shown to have both agonistic and 
antagonistic effects as mentioned in the Introduction. Determination of the three-
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dimensional structure of ERβ with genistein and raloxifene has shed light on the 
possible mechanism of RSV-binding to both ER isoforms (Pike et al. 1999). 
Report by Pike et al showed that the size and shape of ER ligand-binding cavity 
enables the binding of ligands with different structural motifs (Pike et al. 1999). In 
contrast, the cavity shape of thyroid receptor and retinoic acid receptor was shown 
to accommodate ligands with intrinsic flexibility that entails few key interactions 
(Pike et al. 1999).  
The C-terminal end of ER ligand-binding domain (LBD) harbors regions for 
receptor dimerization and ligand-dependent transactivation (AF-2) (Pike et al. 
1999). Each ligand interacts with a specific set of residues and thereby induces a 
distinct conformation in the AF-2 helix (H12). When raloxifene binds to the LBD, 
the bulky side chain protrudes from the cavity and inhibits the physical alignment 
of H12 over the bound ligand. On the other hand, genistein is totally buried within 
the hydrophobic core of ERβ and binds in similar manner to 17β-estradiol – ER 
endogenous hormone. In the ERβ-genistein complex, the orientation taken up by 
H12 is atypical of an agonist’s position but is similar to the position induced by 
ER antagonists. This sub-optimal position of H12 transactivation helix is 
congruent with genistein’s partial agonist function in ERβ. Based on the above 
observations and the pharmacological activities of RSV in their studies, Bowers et 
al posits that RSV bound to ERβ LBD might display similar characteristics to 
genistein binding to ERβ (Bowers et al. 2000). Besides the ER, RSV has been 
shown to physically bind to bovine F1-ATPase (Gledhill et al. 2007), quinone 
reductase 2 (Buryanovskyy et al. 2004) as well as binding to DNA (Fukuhara and 
Miyata 1998). Thus, in the L61.1kb cells, it is possible that RSV might interact 
with AP2 in an antagonistic manner thereby inhibiting the nuclear translocation or 
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binding of AP2 to NHE1 promoter. The first 12 hours after RSV was added to 
L61.1kb cells showed a prominent inhibition of NHE1 promoter activity, 
particularly in the region of -900bp to the AP2+bp region of the promoter. This 
repression could be attributed to RSV-binding to AP2 and negatively regulating 
its function. However, there is no present study on the structural interaction 
between RSV and AP2. 
4.5 RSV induces intracellular acidification and impairs pH recovery rate. 
Following a 48 hour treatment with RSV, L61.1kb and MCF7 cells underwent 
intracellular acidification with a drop of 0.2-0.25 in pH. Concurrently, the 
recovery rate of the RSV-treated cells following an acid load was considerably 
impaired. ROS scavengers such as DMTU and catalase and the use of caspase 
inhibitor zVAD which both salvaged NHE1 protein expression restored 
intracellular pH as well as the pH recovery rate in L61.1kb and MCF7 cells. These 
observations pointed to the potential role of NHE1 in maintaining intracellular pH.  
Indeed, Akram et al demonstrated that down-regulation of NHE1 gene expression 
in NIH3T3 and M14 cells led to significant decrease in intracellular pH as well 
reduced capacity to recover from an acid load (Akram et al. 2006). As RSV has a 
wide range of biological targets, it is very likely that intracellular acidification is 
an accumulation of molecular events that led to repression of key players such as 
NHE1 and other regulatory factors which are critical in maintaining intracellular 
pH. 
NHE1 regulatory factors which influence NHE1 activity constitute the short-term 
regulation of NHE1. For instance, neonatal rat ventricular myocytes (NRVM) 
were treated transiently for 6 min with NH4Cl, washed out in cariporide or HCO3- 
free medium and recovered in Na+ medium demonstrated a fourfold increase in 
 141
NHE1 activity (Haworth et al. 2003). This increase in NHE1 activity was 
counteracted by MEK1/2 inhibitors PD98059 (30µM) or UO126 (3µM), thus 
showing the essence of ERK1/2 in activating NHE1 (Haworth et al. 2003). Since 
RSV has been shown to inhibit ERK phosphorylation in neuroblastomas SH-
SY5Y cells (Miloso et al. 1999), it is very likely that RSV affects ERK in a 
similar way in L61.1kb and MCF7 cells, leading to intracellular acidification. 
Furthermore NHE1 activity was shown to be influenced by PIP2. Depletion of 
ATP resulted in a marked reduction of plasmalemmal PIP2 content (Aharonovitz 
et al. 2000). In addition, sequestration or hydrolysis of plasmalemmal PIP2 in the 
absence of ATP depletion culminated in inhibition of NHE1 activity (Aharonovitz 
et al. 2000). Since RSV has been shown to decrease the steady states of 
phosphoinositide metabolites including PIP2 (Olas et al. 2005), this represents 
another pathway whereby RSV might exert its potential to induce intracellular 
acidification. Carbonic anhydrase (Li et al. 2002a) and Nck-interacting kinase 
(NIK) (Yan et al. 2001a) are two other proteins involved in stimulating NHE1 
activity. Despite the lack of evidence regarding the role of RSV on carbonic 
anhydrase and NIK in the literature, further research is warranted to establish the 
likelihood of RSV impinging on both proteins thereby inhibiting NHE1 activity 
and inducing intracellular acidification and decreased pH recovery rate. Along the 
same lines, somatostatin, D2-dopamine and α2B-adrenergic receptors which are 
known to inhibit NHE1 activity (Lin et al. 2003) have not yet been studied with 
respect to RSV. Subjected to ischemia-reperfusion conditions, NRVM cells 
exhibit increased NHE1 activity owing to the induction of ROS and release of 
intracellular Ca2+ (Rothstein et al. 2002). Besides, RSV has been shown to induce 
cell death via Ca2+-calpain intermediacy in MCF7 and MDA-MB231 cells (Sareen 
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et al. 2007). Although the functions of Ca2+ might vary according to cell lines, it is 
likely that in tumors, RSV-modulation of intracellular Ca2+ might repress NHE1 
expression and activity. 
4.6 RSV mediates cell growth arrest in the G2/M phase. 
Numerous research studies have demonstrated the role of RSV in effecting cell 
arrest as earlier explained in the introductory section 1.5. The findings in this 
present study bring additional evidence that RSV has the ability to induce cell 
arrest. Following treatment with RSV for 48 hours, the growth of L61.1kb cells 
was considerably impaired. A cell cycle profile revealed that there was an 
accumulation of cells in the G2/M phase. Strategies to rescue NHE1 protein 
expression via the use of ROS scavengers and pan-caspase inhibitor, showed a 
decrease in the percentage of cells stalled in the G2/M phase. These results were 
reminiscent of the study which demonstrated that using LAPE muscle fibroblasts 
(containing mutant NHE1 with a defect in its ion translocating ability), there was 
an increase in cells’ arrest in the G2/M phase (Putney and Barber 2004). It is very 
likely that the decrease in NHE1 protein expression and thus intracellular pH 
could be responsible for the cells’ arrest in the G2/M phase. Overexpression of 
NHE1 protein in the L61.1kb cells was later shown to offset the G2/M cells arrest, 
thereby highlighting the role of NHE1 in regulating the transition of cells in the 
G2/M phase. It remains to be determined the role of NHE1 and intracellular pH on 
specific G2/M cell cycle checkpoint regulators. 
4.7 Low dose of RSV induces an increase in intracellular O2.- and NHE1 gene 
expression. 
The fact that RSV possess pro-oxidant abilities has been demonstrated by Ahmad 
et al (Ahmad et al. 2004a). Exposure of human leukemic cells to low 
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concentrations of RSV (4-8 µM) induces an increase in intracellular O2.- level and 
inhibits drug-induced acidification (Ahmad et al. 2004a). These findings link the 
effect of ROS on NHE1 gene expression. Moreover, our lab has shown that 
increase in intracellular O2.- level results in increase of NHE1 protein expression 
(Akram et al. 2006). Indeed, our data show that low dose of RSV has the ability to 
increase intracellular O2.- level as well as NHE1 promoter activity and protein 
expression. Therefore, the increase in resistance to drug-induced apoptosis by low 



















4.8 Model and Conclusion  
The intracellular pathways triggered by RSV leading to generation of intracellular 
ROS, caspase’s activation followed by repression of NHE1 gene expression is 










The findings in this project have unraveled a new mechanism of action of RSV in 
gene regulation. First and foremost, RSV is shown to regulate NHE1 gene 
expression at the transcriptional level – a novel gene target of RSV amidst its 
multiple biological targets. Moreover, RSV induces intracellular ROS which is 
involved in the regulation of NHE1 gene expression. This pro-oxidant nature of 
RSV is an interesting and novel finding as well.  
The fact that RSV activates caspase-3 at an early time point and caspase-6 at a 
later time point reveals an unprecedented order in caspase activation. The 
conventional dogma follows that caspase-3 being an executioner caspase will be 
the final caspase to be activated in a series of caspase activation. In addition, the 
early phase of intracellular ROS seems to be caspase-dependent – an observation 











Last but not least, RSV induction of caspase activation coupled with down-
regulation of NHE1 gene expression did not result in apoptotic cell death in the 














































































(A) L61.1kb cells were transiently transfected with the plasmid encoding human 
catalase and empty vector, pCI-neo. 40 h post-transfection, cells were incubated 
with RSV (128 µM) for 48 h. Single cell suspensions of L61.1kb cells were then 
prepared, stained with PI and analyzed by flow cytometry. Data represent one of 
three independent experiments. 
(B) Pancaspase inhibitor zVAD-fmk (100 µM) was added with or without RSV 
(128 µM) to L61.1kb cells for 48 h in 0.5% FBS. Single cell suspensions of 
L61.1kb cells were then prepared, stained with PI and analyzed by flow 
cytometry. Data represent one of three independent experiments. 
(C) L61.1kb cells were transiently transfected with control siRNA (cosiRNA) and 
specific siRNA to NHE1 (NHE1siRNA). 40 h post-transfection, cells were 
exposed to RSV (128 µM) for 48 hours. Single cell suspensions of L61.1kb cells 
were then prepared, stained with PI and analyzed by flow cytometry. Data 
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